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ISummary
The “Report on the drug situation in Austria” commissioned by the European Monitoring
Centre for Drugs and Drug Addiction and the Federal Ministry for Social Security and
Generations appears annually and addresses the subject of illegal drugs. The report gives an
overview of current developments regarding the political and legal framework, the epidemio-
logical situation and demand reduction measures. In addition, key issues are presented; this
year “Drug strategies”, “Cocaine and base/crack cocaine“ and “Infectious diseases” were
selected for detailed presentation.
What are the changes that have occurred regarding the legal, political
and organisational framework?
In the reporting period 1999/2000 new drug plans or addiction plans which define drug policy
guidelines for the years to come and partly contain concrete sets of implementation
strategies were adopted in the provinces of Lower Austria, Salzburg and Styria. All three
plans emphasise a balanced, comprehensive and integrative approach, which is in line with
the drup policy principles that have been established in Austria over the past decades. The
Lower Austrian Addiction Plan includes legal as well as illegal substances and underlines the
comprehensive nature of drug work, which should operate at the societal as well as on the
individual level. The Salzburg drug plan defines the reduction of health and social harm
resulting from drug consumption as a priority aim and is based on a systemic approach and
on the principle of orientation towards concrete needs. The Styrian drug plan underlines the
need for a network of various therapy modules ranging from survival assistance to help in
regaining social integration and self-determination.
At the federal level drug policy objectives were included in the government programme of
February 2000. In the section on health, plans to intensify prevention measures and reduce
the decreed “limit quantities” should be mentioned. A draft on reducing the limit quantities,
which would be relevant both for the severity of punishment and the possibility of applying
alternatives to punishment, was sent out for examination  in summer 2000. The direction of
drug policy also came up very frequently in the media over the past months. Experts have
criticised what they perceive as a turn towards a more repressive drug policy, while individual
representatives of the government coalition have questioned the success of the drug policy
line taken so far.
What are the characteristics of the drug situation in Austria?
The present data and information on the epidemiological situation in Austria confirm the
trends of previous years. By and large, the extent of problem use of illegal drugs is
considered to be stable. For the first time results of a nationwide scientific prevalence
estimate are available, according to which there are approximately 15,000 to 20,000 problem
opiate users, half of which were registered in Vienna. As to consumption patterns, polydrug
use (i. e. the consumption of various substances), mixed consumption and intravenous
administration continue to be of special relevance. In Vienna there is evidence that cocaine
and morphine tablets, primarily used intravenously, are gaining in importance within polydrug
use.
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The development of drug-related deaths was also found to have stabilised in long-term
comparison. In 1999 there were 174 drug fatalities, which is slightly above the 1998 figure,
but clearly below the high figures of the mid-nineties (1994: 250 cases). The number of drug
fatalities resulting from mixed intoxication have risen, while the number of intoxications
exclusively caused by a psychotropic substance have continued their downward trend. In
Vienna, where corresponding data is available, the decline of non-lethal overdoses that has
been observed for some years has continued. The HIV prevalence in IDUs has remained
constant at a low level of below five percent, while the hepatitis prevalence rates continue to
be high (see below). Unemployment and homelessness still constitute major social problems
of drug addicts.
Cannabis is the illegal substance for which consumption experience is indicated most fre-
quently. In new surveys approximately one third of adolescents or young adults report to
have experience of cannabis consumption, which is a somewhat higher figure than re-
gistered before. Other than that, however, there are no indications of increasing drug
experience according to recent representative surveys, as the figures for all other substances
have remained at the level of the preceding years. Accordingly, approximately four percent of
the young people have experience of ecstasy and between one and a maximum of two per-
cent have experience of heroin or cocaine. A recent youth survey, which however does not
claim to be representative, confirms interrelations between specific youth cultures and
(experimental) use of drugs, especially in the rave culture, which is known for its high drug
affinity.
Which health policy measures have been taken to tackle the drug
problem?
Regarding health policy measures, first of all the existing approaches have been continued
or developed further. In line with the principles of need and demand orientation, new services
are often planned and designed on the basis of requirements defined in the course of
practical work. As in previous years a few new focal issues have emerged in the reporting
period. In the field of prevention the workplace has become a more important setting for
implementing drug-related activities: in almost all provinces projects of addiction prevention
in the workplace are being run. In addition new media, and especially the Internet, have
played an increasingly important role for providing information. The endeavours of last year
in particular to expand secondary prevention and early intervention services (aimed at
specific target groups) have been continued. Many regions also plan to establish new or
complementary outreach and low-threshold drug help services.
The trend towards a regionalisation of relevant facilities still continues and is becoming more
and more obvious not only in the field of prevention but in the whole area of drug help. Euro-
pean cooperation projects also continue to play a central role. In the whole field of demand
reduction measures the aspect of quality assurance is rapidly gaining in importance. As a re-
sult, an increasing number of projects are evaluated, and the planning, implementation and
evaluation stages are accompanied by research activities. Another aspect of quality
assurance is that minimum requirements and quality standards for drug help activities are
defined and implemented and that education and (further) training schemes for drug experts
and other groups concerned with the problem of drugs are intensified.
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Key issue “drug strategies”
Drug strategies are defined in the drug plans or addiction plans that have been drawn up in
seven out of nine provinces so far. Due to the federalist structure of the field of health and
social affairs the provinces play a major role in planning and implementing drug policy
measures. At present no complementing national strategy has been defined at the federal
level, although the central objectives and principles of the national drug policy as it is
practised provide the foundations for the relevant laws. Therefore the national drug policy of
Austria aims at a “comprehensive and balanced approach” and follows a strategy that
emphasises the distinction between drug dependence and drug trafficking. As drug addiction
is defined as a disease in a psychosocial context help for addicted patients, by means of
social and health policy measures, shall have priority over repressive methods. This principle
is also found in the legal provisions that define alternatives to punishment and the model
“therapy instead of punishment” for addicted offenders. The measures taken by the police
and the judicial authorities are primarily aimed at drug control and especially the prevention
of illegal drug trafficking.
The main objective of the Austrian drug policy is a society as free of addiction as possible. In
addition to approaches aimed at complete abstinence, in the last few years the importance of
measures of accepting assistance have been underlined, with the objective of limiting drug-
related risks and damage wherever possible. In this regard the health policy aim is to provide
a set of integrated measures of prevention, treatment, reintegration and accepting assistance
aimed at risk minimisation in a diversified, multiprofessional help network.
Key issue “cocaine and base/crack cocaine”
Only few information and data concerning cocaine are available in Austria, which, among
other reasons, is due to the fact that the group of persons who exclusively use cocaine tend
to be socially inconspicuous. As shown by a number of representative studies a maximum of
one or two percent of the population have experience of cocaine. It is estimated that there
are approximately between 10,000 and 15,000 cocaine problem users in Austria, comprising
three relevant groups: young drug users experimenting with many different substances,
persons consuming no other illegal substance than cocaine and persons who use cocaine
among other drugs in the context of polydrug use. Use of crack has not played an important
role in Austria so far.
Regarding health and social problems caused by cocaine use there is hardly any information
available. There are only few drug-related fatalities annually that were primarily caused by
cocaine. On the other hand the combined use of heroin and cocaine (“speedballs”) found in
the open drug scene poses a serious health risk. So one may assume that cocaine is also
involved in polydrug use, combined with opiates. With regard to the need for treatment
caused by cocaine there is no data concerning persons who only take cocaine. However, it
has been observed that this group of persons do not tend to turn to typical drug facilities,
which would be open to them as well. To our knowledge there are no specialised facilities or
programmes for cocaine users. In addition, the actual demand for programmes specifically
aimed at cocaine users can hardly be estimated as it is assumed that most persons of the
“upper cocaine scene” would not turn to “traditional” drug help facilities in case of problems.
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Key issue “infectious diseases”
The problems of infectious diseases among intravenous drug users have been a central
health policy issue for many years. Until the late 1980s the main focus was placed on HIV, as
it was estimated that up to 20 percent of the injecting drug users were infected at that time. In
the meantime the infection rate has been considerably reduced and at present it is not higher
than five percent but rather even lower, so in the last few years the prevention of hepatitis
has played a major role as the corresponding prevalence rates are very high. According to
various drug help facilities the current hepatitis C prevalence rates range from 35 to more
than 80 percent, depending on the sample, and in the case of hepatitis B they are between
approximately 10 and more than 60 percent. No definite reason for the marked differences
reported can be given. They may be due to regional differences or differences regarding the
group of clients receiving counselling or treatment. The results of a Viennese survey on risk
factors with regard to hepatitis B do not indicate a significant relation between infection rates
and typical features of the persons concerned (e.g. age, duration of drug use, prostitution).
On the other hand, imprisonment turned out to be a central risk factor, and in a complemen-
tary study very high prevalence rates were found among clients who shared injecting equip-
ment in prison.
Preventing infectious diseases has also been a focus of health policy interventions. In this
context it is especially important that syringes are available to drug users as intravenous drug
use is very common in Austria. This is ensured by a number of specific services (syringe
exchange programmes, syringe vending machines). In addition information on safe use and
safe sex is provided, and condoms and anonymous cost-free tests are offered. By now many
drug facilities have also offered vaccination against hepatitis A and B. Measures aimed at
preventing infection are also taken in prisons. At the beginning of imprisonment every
prisoner is given a so-called care pack containing information folders on HIV, condoms etc.,
moreover condoms and disinfectants are available in almost every prison. Recently a
number of working groups were established to draw up an overall strategy for the prevention
of hepatitis. A Viennese working group has already prepared corresponding recommen-
dations, which are being dealt with by a working group of the National Health Board, which is
responsible for drawing up a set of measures for the whole country.
VContents
Introduction..................................................................................................................................1
PART 1: National Strategies: Institutional and Legal Framework
1 Developments in drug policy and responses.........................................................................5
1.1 Political framework in the drug field....................................................................................5
1.2 Policy implementation, legal framework and prosecution .....................................................7
1.3 Developments in public attitudes and debates ....................................................................8
1.4 Budget and funding arrangements .....................................................................................9
PART 2: Epidemiological Situation
2 Prevalence, patterns and developments in drug use ............................................................ 13
2.1 Main developments and emerging trends ......................................................................... 13
2.2 Drug use in the population............................................................................................... 13
2.3 Problem drug use............................................................................................................ 15
3 Health consequences........................................................................................................... 17
3.1 Drug treatment demand................................................................................................... 17
3.2 Drug-related mortality...................................................................................................... 19
3.3 Drug-related morbidity..................................................................................................... 22
4 Social and legal correlates and consequences.................................................................... 23
4.1 Social problems .............................................................................................................. 23
4.2 Drug offences and drug-related crime............................................................................... 24
4.3 Social and economic costs of drug consumption............................................................... 26
5 Availability and supply of drugs........................................................................................... 27
6 Trends per drug.................................................................................................................... 29
7 Discussion............................................................................................................................ 31
PART 3: Demand Reduction Interventions
8 Strategies in demand reduction at national level ................................................................. 35
8.1 Major strategies and activities .......................................................................................... 35
8.2 Approaches and new developments................................................................................. 36
VI
9 Intervention areas................................................................................................................. 37
9.1 Primary prevention.......................................................................................................... 37
9.2 Reduction of drug-related harm........................................................................................ 39
9.3 Treatment....................................................................................................................... 41
9.4 Aftercare and reintegration .............................................................................................. 42
9.5 Interventions in the criminal justice system ....................................................................... 43
9.6 Specific targets and settings ............................................................................................ 44
10 Quality assurance ................................................................................................................ 47
PART 4: Key Issues
11 Drug strategies in Austria .................................................................................................... 51
11.1 National policies and strategies........................................................................................ 51
11.1.1 Principles of national drug policy........................................................................... 51
11.1.2 Provincial drug plans............................................................................................ 52
11.2 Application of national strategies and policies ................................................................... 54
11.2.1 Organisational framework of drug policy................................................................ 54
11.2.2 Implementation of drug policy principles ................................................................ 55
11.2.3 Evaluation ........................................................................................................... 57
12 Cocaine and base/crack cocaine.......................................................................................... 59
12.1 Different patterns and user groups ................................................................................... 59
12.2 Problems and needs for services ..................................................................................... 62
12.3 Market............................................................................................................................ 62
12.4 Intervention projects........................................................................................................ 63
13 Infectious diseases............................................................................................................... 64
13.1 Prevalence and incidence of HCV, HBV and HIV  among drug users.................................. 64
13.2 Determinants and consequences ..................................................................................... 67
13.3 New developments and uptake of prevention/harm reduction, care .................................... 69
References...............................................................................................................................73
Annex
VII
Tables, Figures and Maps
Tables:
Table 13.1: Hepatitis C prevalence results of the testing service of the
low-threshold facility Ganslwirt according to age and gender
from October 1998 to July 2000................................................................................... 65
Table 13.2: Hepatitis C prevalence among IV drug patients of the short-term
therapy department Lukasfeld from 1995 to August 2000.............................................. 65
Table 13.3: Hepatitis B prevalence among IV drug patients of the short-term
therapy department Lukasfeld from 1996 to August 2000.............................................. 68
Table A1: Estimated expenses related to illegal drugs in Austria in 1997 ....................................... 89
Table A2: Overview of selected studies on drug experience among the Austrian
population, published between 1996 and 2000 ............................................................. 89
Table A3: Lifetime prevalence of illegal drugs among the Viennese population
 in Vienna aged 16 years and older 1993 – 1999 .......................................................... 90
Table A4: Overview of the results of a prevalence estimate of problem opiate
consumption in Austria 1995........................................................................................ 90
Table A5: Number of drug fatalities in Austria by cause of death
from 1990 to 1999....................................................................................................... 90
Table A6: Number of drug fatalities in Austria by province
from 1990 to 1999....................................................................................................... 91
Table A7: Number of drug fatalities in Austria by age group and total
by gender from 1990 to 1999....................................................................................... 91
Table A8: Distribution of drug fatalities in Austria by cause of death
and age in 1999.......................................................................................................... 92
Table A9: Distribution of drug fatalities in Austria by cause of death
and province in 1999................................................................................................... 92
Table A10: Development of AIDS cases in Austria by risk situation
from 1990 to 1999....................................................................................................... 92
Table A11: Distribution of reports to the police for violations of the Narcotic Drugs Act/
Narcotic Substances Act in Austria by first offenders and repeat offenders
and development from 1990 to 1999 ............................................................................ 93
Table A12: Distribution of reports to the police for violations of the Narcotic Drugs Act/
Narcotic Substances Act in Austria by province from 1990 to 1999 ................................ 93
Table A13: Distribution of reports to the police for violations of the Narcotic Drugs Act/
Narcotic Substances Act in Austria by drug type from 1990 to 1999............................... 93
Table A14: Distribution of reports to the police for violations of the Narcotic Substance Act
in Austria by drug type and province in 1999................................................................. 94
Table A15: Convictions under the Narcotic Drugs Act/Narcotic Substances Act and total
number of convictions in Austria from 1990 to 1999 ..................................................... 94
Table A16: Final convictions under the Narcotic Drugs Act/Narcotic Substances Act
in Austria by age, gender and reason for conviction in 1999 ......................................... 95
VIII
Table A17: Final convictions under the Narcotic Drugs Act/Narcotic Substances Act,
according to youths and adults, reason for conviction and form of
punishment in 1999..................................................................................................... 95
Table A18: Number of seizures of narcotic drugs in Austria from 1990 to 1999 ................................ 96
Table A19: Seizures of drugs in Austria by quantity from 1990 to 1999............................................ 96
Table A20: Austrian population statistics by age group and gender 1999......................................... 97
Figures:
Figure 3.1: Development of annual registrations of persons currently undergoing
substitution treatment in Austria from 1990 to 1999, by first treatments
and continued treatments............................................................................................ 18
Figure 3.2: Distribution of persons currently registered for substitution treatment
in Austria by age and gender in 1999 ........................................................................... 19
Figure 3.3: Number of drug fatalities in Austria by cause of death from 1990 to 1999....................... 20
Figure 3.4: Age distribution of drug fatalities in Austria from 1990 to 1999 ....................................... 21
Figure 4.1: Development of reports to the police for violations of the Narcotic Drugs Act/
Narcotic Substances Act by misdemeanours and felonies in Austria from
1990 to 1999.............................................................................................................. 24
Figure 4.2: Development of reports to the police for violations of the Narcotic Drugs Act/
Narcotic Substances Act in Austria by drug type from 1990 to 1999............................... 25
Figure 5.1: Number of seizures of narcotic drugs in Austria from 1990 to 1999 ................................ 27
Figure A1: Organisational structure of the drug sector in Austria (Overview) ................................... 98
Figure A2: Attitude of the population in Vienna on drug policy measures over time,
1995 - 1999................................................................................................................ 99
Figure A3: Number of syringes sold or exchanged in the context of the syringe
programme in the open drug scene in Vienna from 1993 - 1999..................................... 99
Maps:
Map 1: Overview of the Austrian provinces, provincial capitals and districts ................................... 100
Map 2: Specialised facilities for treatment, counselling of and assistance to drug patients............... 101
Map 3: Specialised offers for treatment, counselling of and assistance to drug patients .................. 102
1Introduction
For the fifth time the Austrian REITOX Focal Point established at the Austrian Health Institute
(ÖBIG) presents its annual Report on the Drug Situation commissioned by the European
Monitoring Centre for Drugs and Drug Addiction (EMCDDA) and the Austrian Federal
Ministry for Social Security and Generations (FMSSG).
The present report serves both as an overview of the situation in the field of illicit drugs in
Austria and as one of the national contributions describing the drug situation in the European
Union. Reports of its kind are submitted by the REITOX Focal Points in all EU member states
according to a structure fixed by the EMCDDA. These reports form the central basis of the
EMCDDA‘s Annual Report on the State of the Drugs Problem in the European Union
(EMCDDA 1999).
In this year’s report, some changes as to structure have been made. The first three parts
deal with current developments and trends concerning the drug policy framework, the
epidemiological situation and the health policy measures aiming at demand reduction. These
parts refer to the reporting period from summer 1999 to summer 2000 and to the routine
statistics of the year 1999. As they are based on the previous reports (ÖBIG 1996, 1997,
1998, 1999a), they have been kept concise deliberately. Part 4 contains a detailed presen-
tation of selected key issues. The key issues of the present report are "Drug strategies in
Austria", "Cocaine and base/crack cocaine" and "Infectious diseases". The Annex includes
tables, figures and maps with detailed information and data as well as an overview of the
major sources of information and drug monitoring systems in Austria.
The report is based on many different data transmitted to ÖBIG by various experts in the field
of drugs during the reporting year. In this respect, the reports and information on the
individual Austrian provinces provided by the Drug Coordinators were especially significant.
We would like to express our gratitude for their cooperation.
We are especially indebted to Mr. Peter Hacker (Drug Policy Co-ordinator of the City of
Vienna), Ms. Elfriede Fritz (FMSSG), Mr. Alexander Jentzsch (FMSSG), Ms. Brigitte
Magistris (FMSSG), Ms. Helga Oberarzbacher (Drug Coordinator of the Province of the
Tyrol), Mr. Robert Scharinger (FMSSG), Ms. Johanna Schopper (FMSSG) and Mr. Wolfgang
Werdenich (FMJ), whose comments on and complements to the present report were most
helpful.

PART 1
National strategies:
Institutional and legal frameworks

51 Developments in drug policy and responses
1.1 Political framework in the drug field
In the reporting year, again several activities to lay down the drug policy framework in written
form were registered at the province level. In three provinces new drug plans (cf. also
Chapter 11.1.2) were adopted, which are based on the traditional Austrian drug policy
principles (for a detailed presentation of the drug policy principles see Chapter 11) and
underline a balanced, comprehensive, differentiating and systemic approach. In the Salzburg
drug plan of 1999, reducing the health and social harms caused by drug consumption – by
means of preventing first consumption and taking health and social policy measures in favour
of consumers, those in danger of becoming addicted, and addicts – is defined as the priority
aim of drug policy measures. Based on the principle of orientation towards concrete needs
and an integrated (systemic) as well as integrative approach, the drug plan comprises all
fields of measures ranging from prevention and low-threshold services to treatment and
social reintegration (cf. also Chapter 8.1). The Styrian drug plan was adopted by the pro-
vincial parliament in June 2000. It has been conceived as a framework strategy for tackling
drug issues with the aim of creating a dense network consisting of various therapy modules
with objectives ranging from survival assistance to persons endangered by drugs to
recovering and strengthening their individual abilities and competence to lead drug-free lives.
The Lower Austrian drug plan was adopted by the provincial parliament in July 2000. Also
designed as a framework plan for tackling drug issues, it comprises legal as well as illegal
substances. Based on the WHO concept of health promotion, a comprehensive view of drug
issues is taken, which relates to the individual as well as to the broad context of societal
tasks such as economic, social, family and health policy.
Also in other provinces, the development and adaptation of drug policy guidelines is under
way. In the Tyrol, the 1993 drug plan is up for evaluation in the coming months and will
consequently be revised in the form of a comprehensive addiction plan (cf. also Chapter
11.2.3). Similarly, in Carinthia the 1995 drug plan is currently under review. Moreover, drug-
specific aspects will be included in the Carinthian psychiatry plan, which is being prepared at
present.
At the federal level there is still no fixed drug strategy (cf. also Chapter 11.1.1). In the
reporting period Austria has confirmed the adherence to a balanced drug policy by adopting
the EU Drugs Strategy 2000 – 2004 (endorsed at the meeting of the European Council in
December 1999) and the corresponding Action Plan (endorsed at the meeting of the
European Council in June 2000).
In the programme of the Austrian government issued on 9 February 2000, drug-specific
measures are included primarily in the fields of health and interior safety. In the chapter
referring to health policy goals ("Programm für mehr Gesundheit in Österreich“) the section
relating to addictive substances lists the following positions (p. 39):
· primary prevention among persons suffering from drug addiction shall be intensified
· "therapy instead of punishment“: all prescribed therapies shall be continued until they
have been completed
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· no legalisation of "soft drugs”, "reduction of the permitted limit quantities“
In addition the chapter on safety, security and integration ("Innere Sicherheit und
Integration“) includes the following drug-specific intentions (p. 46):
· information campaigns for young people in order to prevent drug consumption and drug-
related crimes, in co-operation with the Ministry of Education, courts, the Ministry of
Health and the ministerial family department
· uncompromising fight against drug trafficking, using all legal means and employing the
staff that is needed for such operations as well as providing the necessary infrastructure
for the police (special state-of-the-art  task forces).
During the past few months the government underlined its adherence to a balanced drug
strategy and to the principle of "therapy instead of punishment", but at the same time has
shown its intention to interpret these principles more repressively, which would constitute, at
the least, a gradual departure from the drug policy applied up to now. This development has
been criticised by many experts in the field of drugs (cf. also Chapter 1.3), who oppose a turn
towards a more repressive drug policy. The nationwide Drug Forum, a coordinating body with
representatives from the federal ministries, the provinces and drug experts (cf. Chapter
11.2.1), which in May 2000 discussed the measures outlined in the government programme,
voiced its opposition to some of the plans included there.
It was pointed out that most of the goals listed in the government programme in the chapter
on health refer to legal rather than health measures, which appears to counteract the priority
of health and social policy measures over repressive action. The Drug Forum also criticised
that the government programme stresses the competence of the Ministry of the Interior
regarding information campaigns for young people, as this puts addiction prevention into the
context of crime prevention, which runs counter to the traditional principles. The plans regar-
ding a general intensification of prevention measures, on the other hand, were applauded.
Concerning the reduction of the limit quantities as included in the government programme, a
draft revised version of the decree regulating the limit quantities of narcotic substances was
sent out for examination, according to which a reduction of the heroin quantity defined as
"large" is planned (cf. Chapter 1.2). The main argument put forward by the Drug Forum
against this move was that alternatives to punishment would be applied less frequently,
which contradicts the health policy aims of the Narcotic Substances Act (cf. Chapter 1.2) with
regard to the principle of "help instead of punishment”.
Some of the planned measures also question the disease-like nature of drug addiction.
According to a decree issued by the Ministry of Justice, not only all prisoners convicted of
crimes under the NSA, which were already excluded from the traditional Christmas pardon
by the Austrian President in previous years, but also all those convicted for an offence
connected to addictives substances are ineligible for the Christmas pardon. This means that
contrary to traditional practice, no distinction is made between drug users, addicts and drug
dealers.
As to the organisational framework (cf. Figure A1 of Annex B) further expansion can be
observed at the federal level. In Lower Austria, a new Drug Coordinator in charge of imple-
menting the Addiction Plan was appointed on 1 July 2000. In the province of Burgenland the
position of Drug Coordinator that was vacant for some time has now been filled, and the
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newly appointed Drug Coordinator will enter into office on 1 October 2000. Also in the
province of Styria, there are plans to appoint a Drug Coordinator. At the federal level, how-
ever, the structural framework has remained largely unchanged.
1.2 Policy implementation, legal framework and
prosecution
In the reporting period there were no changes regarding the legal framework regulating the
field of drugs (cf. ÖBIG 1999), however, the government has plans in this direction. In
September 2000 a proposal for revising the Narcotic Substances Act (NSA) was sent out for
examination. The main provision included in the proposal for an amendment of the NSA was
an increased penalty for (organised) drug trafficking.
As mentioned above, the government has also voiced plans to reduce the legally defined
limit quantities. The quantities determined in the "decree on limit quantities of narcotic
substances" are destined to draw the line between misdemeanours (acquisition, possession,
production, import, export etc. of a narcotic substance, as regulated under Art. 27 of the
NSA) and felonies (acquisition, possession, production, import, export etc. of a narcotic
substance in large quantities, as regulated under Art. 28 of the NSA). This distinction is
relevant in two ways: first, the penalty for felonies is much higher, and second, only in the
case of misdemeanours there is the possibility of preliminary withdrawal of reports by the
public prosecutors (as regulated under Art. 35) and preliminary dismissal of proceedings by
the court (as regulated under Art. 37).
Furthermore, the definition of a "large quantity" has immediate effects on the application of
Arts. 35 and 37 of the NSA. Preliminary (provisional) withdrawal of reports or dismissal of
proceedings may be applied if someone has been reported to the police for acquiring or
possessing a small quantity of a narcotic substance for their own use. While the level of a
"large quantity" is precisely fixed in the decree on limit quantities, there is no such definition
for "small quantities". According to judicial decisions, there shall be a marked difference
between a "small quantity" and the "limit quantity". For each individual case, the issue of
whether a specific quantity of drugs may be considered small shall be resolved by the public
prosecutors and the competent court, based on the limit quantity on the one hand and on
individual doses and daily doses for unaddicted persons and addicts on the other.
In the decree on limit quantities of narcotic substances (BGBl II 1997/377) the following
quantities in terms of the pure substance of the active substance in question are listed:
cannabis: 20 g THC, heroin: 5 g, cocaine: 15 g, amphetamines: 10 g, MDMA: 30 g. In the
draft for a revision of the decree on limit quantities of narcotic substances sent out for
examination in July 2000, a reduction of the limit quantity for heroin from five to three
grammes is proposed. This would have the effect that in the future a greater number of
delinquents would be convicted for violation of Art. 28 of the NSA and that the alternatives to
punishment would be applicable in fewer cases. Subject to the approval of the Main
Committee of the Austrian Parliament, the decision on reducing the limit quantities will be
taken in autumn 2000.
Another issue that was discussed in the reporting period was the legal framework for using
cannabis for medical purposes. Already at the end of 1998, the Vienna City Council adopted
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a resolution on admitting cannabis for medical purposes by majority rule. In legal
examination it was found that the NSA prohibits all forms of consumption of the flowers and
fruit of the plants belonging to the genus cannabis where the resin has not been extracted.
The medical use of other cannabis products, however, is permitted. The decree on narcotic
substances explicitly mentions delta-9-tetrahydrocannabinol, which is in pharmaceutical use,
as a substance for which prescriptions may be issued (decree on narcotic substances, BGBl
II 1997/374). However, no pharmaceutical of this type has yet been admitted to the Austrian
market, so it would be difficult to acquire. The FMSSG has commissioned the Austrian
Health Institute, within its field of activities under the heading "Evidence Based Medicine“, to
conduct an expert study on the state of knowledge concerning the fields of application,
therapeutical effects and possible side-effects. The results of this study will be presented in
autumn 2000.
1.3 Developments in public attitudes and debates
In Vienna another public opinion poll on the theme of addictive substances was carried out at
the end of 1999. In general its results confirmed the clear acceptance of drug policy
principles such as therapy instead of punishment, diversified problem-solving strategies, etc.
(cf. Chapter 11.1), which had already been registered in the polls of the years 1995, 1996
and 1997. Comparing the results over the years, a trend towards a more liberal attitude may
be noted, which shows for instance in the increasing approval of "legalising hashish" (from
13% in 1995 to 24% in 1999) and of "distributing sterile injection equipment to addicts"  (from
45% in 1995 to 64% in 1999) paralleled by a decreasing approval of "imprisonment for drug
use“ (from 27% in 1995 to 19% in 1999; cf. Figure A2 of Annex B). Another measure, "setting
up rooms for IDUs“, was considered (very) appropriate by 25% of the respondents. On the
other hand, complete liberalisation of drug consumption and trafficking is opposed by 80% as
not (at all) appropriate. Indirectly, the results also serve as an indication of the attitude
towards drug addicts: approximately 80% of the respondents would accept a drug
counselling centre established near where they live, and almost 90% would not mind at all
(60%) or would not mind very much (22%) if their general practitioner also engaged in the
treatment of drug addicts (Feistritzer 2000).
In Vorarlberg a TED poll on cannabis especially addressing young people was carried out in
spring 2000. Of the 12,000 votes that were registered, 67% were in favour of legalising
cannabis "unconditionally", another 5% were in favour "under certain conditions", and 28%
were against legalising cannabis. This confirms the results of a new study among youths
(Springer et al. 1999), according to which cannabis has increasingly gained the status of an
"illegal routine drug" (cf. Chapter 2.2). The second question of the TED poll referred to the
appropriateness of addiction prevention, which 91% approved of ("yes, to prevent drug
incidents is better than reacting to them"), while 9% disapproved ("no, the money should be
spent on police measures instead"; see http://treffpunkt.vol.at/ tools/ted/ted-stand-chart.asp,
28 April 2000).
The drugs issue repeatedly came up as a subject of public debate during the past few
months, with a broad range both of opinions that were stated and forms of media coverage.
On the one hand, part of the media showed an increasing readiness to differentiate in their
discussion of the problem of drugs, which resulted in factual information and balanced
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reports that were presented. On the other hand, a lot of media continued to issue rather one-
sided, "dramatising" contributions on the subject.
As a result of the demand voiced by individual politicians that specific population groups
(such as pupils, teachers, police) should be tested for drugs, in spring and summer 2000 the
drugs issue repeatedly appeared in the media, albeit for a short time in each instance. A few
politicians supported the demand via media, but there were strong doubts as to whether such
a measure would be appropriate or could be financed. Another focus of attention in spring
and summer 2000 was the debate on the measures planned by the government. Several
competent province authorities and drug experts criticised the announced financial cuts in
the field of drugs (cf. Chapter 1.4) as well as the planned reduction of limit quantities (cf.
Chapter 1.1 and 1.2). During the summer of 2000, the issue of drug policy received strong
media coverage. Some representatives of the governing parties questioned the success of
the policy that has been followed up to now. On the other hand, experts voiced their criticism
of the apparent turn in the direction of more repressive measures.
Another matter that frequently came up in public debate was cannabis. One example was the
controversy between police representatives criticising what they saw as an increasing
tendency to understate the importance of cannabis and asking for more repressive measures
on the one hand and prevention experts opposing the view of cannabis as a first drug with
great health hazards, which invariably leads to the use of other drugs (cf. e.g. the Austrian
daily "Der Standard", 28 May 2000). The "myths" and problems surrounding cannabis were
also discussed in the Upper Austrian addiction advisory board and became the subject of
several mailings (e. g. an information sheet on cannabis entitled "Infoblatt Cannabis: hoch-
gelobt und verteufelt“ on the alleged merits and dangers of cannabis).
1.4 Budget and funding arrangements
For the first time a study on the comparison and analysis of economic aspects of the problem
of illegal drugs in Austria (Bruckner and Zederbauer 2000) was drawn up, commissioned by
the Healthy Austria Fund and carried out by the Institute of Social and Societal Policy at the
University of Linz and the Institute for Addiction Prevention also based in Linz. It gives an
overview of financial means spent on measures to combat illegal drugs in Austria. Based on
available data for the year 1997, the study gives a total estimate of more than 2,000,000,000
Austrian Schillings (ATS; approximately EUR 50 million) of expenses in the various fields, of
which almost two thirds are spent in the field of law enforcement (police, legal measures).
The remaining third goes into drug help (ATS 690 million, i. e. approximately EUR 50 million)
and into prevention (slightly less than ATS 40 million, or approximately EUR 3 million; cf.
Table A1 of Annex B). Because of shortcomings in the data base (one example is the fact
that due to insufficient information, expenses in connection with combatting offences
committed in connection with the acquisition or consumption of drugs or expenses for
substitution treatment and aftercare were not included), the figures given in this study can
only be regarded as very rough estimates, but still they indicate the order of magnitude of
expenses in this field.
As to the current budget and funding arrangements, the so-called budgetary economies
embarked upon by the federal government have also resulted in cuts of the federal means
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for health policy measures in the field of drugs. To give an example, the budget of the health
department of the FMGSS for promoting drug help services and the Addiction Prevention
Units has been cut down from ATS 23 million (approximately EUR 1.7 million) to less than
ATS 20 million (approximately EUR 1.4 million). Moreover, the drug help facilities are hit by
the drastic reduction in the number of posts for persons performing alternative military
service, many of whom used to be employed in drug service. For the most part these cuts
cannot be compensated for by the Provinces, as the increasing shortage of available means
also affects the provincial level. Consequently, many drug help facilities face the problem of
having to make do with reduced resources in the future.
PART 2
Epidemiological
Situation
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2 Prevalence, patterns and developments
in drug use
2.1 Main developments and emerging trends
Recent studies on drug consumption have shown hardly any changes as to the number of
illegal drug users in relation to the total population. However, some studies carried out in the
past few years indicate that experimental use of drugs is rising among young people. There
is a relatively clear link to specific youth cultures or "scenes"; a significant example is the
rave culture, which is known for its high drug affinity. In this scene synthetic drugs (especially
ecstasy and amphetamines) play a major role, while in other subcultures (e. g. fun sports)
cannabis is of importance.
However, the registered increase in experimental use has not resulted in a rising number of
"problem drug users" or drug addicts so far. Here the overall situation and that of young
people in particular is viewed as stable. According to a recent prevalence study, the number
of problem opiate consumers all over Austria is estimated to lie between 15,000 and 20,000
persons. Polydrug use and intravenous use continue to be the prevalent consumption
patterns. In Vienna, there is evidence that both cocaine and morphine tablets have gained
importance in multiple and mixed drug use, with injecting use as the favoured mode of
consumption for both substances. This development has been attributed to market develop-
ments such as falling cocaine price and a rise in morphine tablets available on the illegal
drug market.
2.2 Drug use in the population
In the course of the reporting period several new studies on the use of illegal drugs among
the general population and specific target groups were published. Apart from a study among
the Vienna population the focus is again on young people.
In Vienna, the IFES Institute for Empirical Research was commissioned by the Drug Co-
ordination Office of the City of Vienna to draw up a representative enquiry among the
population over 16 years of age on the issue of drugs and drug policy (cf. also Chapter 1.3).
The design of the study, which is carried out every two years, has remained constant since
1993, which allows for time series comparisons. The results regarding lifetime consumption
experience have remained virtually unchanged over the past few years. The only drug that
yields statistically relevant results for consumption is cannabis (11%), which is also the only
drug where figures have risen compared to the years 1993 (5%) and 1995 (7%), but re-
mained fairly equal compared to the preceding enquiry in 1997 (12%). For all other
substances consumption experience results are between one and two percent, i. e. at a level
that is too low for statistical comparisons over time (cf. Table A3 of Annex B).
Lifetime use of cannabis has been found more frequently in men (13%) than in women (9%).
Here, a clear difference as to age groups/clear age differential is registered. The figures for
reported lifetime use are 33 percent among the 16 to 24 year-olds, but only 22 percent
among the age group between 25 and 34 years, 9 percent among the 35 to 44 year-olds and
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 approximately two percent among the respondents over 45. In the enquiry the respondents
were also asked to indicate whether they had used drugs within the past three years and the
past 30 days. The corresponding figures for cannabis are 8 percent and 2 percent,
respectively, for other substances one percent and at a low per mille level, respectively (IFES
2000).
In the Tyrol a youth study with a focus on analysing risk and protection factors regarding drug
use was carried out in 1999. A representative sample of youths from all schools of the
province capital Innsbruck aged between 14 and 19 were selected. Regarding illegal
substances, a distinction was made only between cannabis and other drugs. A total of 22
percent of the respondents reported to have had experience of hashish – nine percent had
tried it, 13 percent were regular users – while three percent indicated use of other illegal
drugs (Schüßler et al. 2000). Compared to earlier studies among youths and in schools the
figures regarding cannabis use are relatively high, but they confirm the results of both a study
carried out in Linz/Upper Austria (cf. Table 2 of Annex B) last year and the above-mentioned
study among youths and adults in Vienna (see above).
The Federal Ministry for Social Security and Generations (FMSSG) commissioned a study on
the significance and consumption of psychoactive substances among Austrian youths
(Springer et al. 1999) with the aim of analysing the interrelations between the participation in
specific youth cultures and use of drugs. For this purpose 50 youths for each culture – "rave",
"fun sports", "youth associations" and a control group – were interviewed by youths from the
respective scene who were especially trained for the task. The study was directed at gaining
qualitative insights that may be applied in prevention work rather than quantitative data,
therefore it does not claim to be representative. As to consumption, the figures were high for
lifetime use of cannabis (67%), ecstasy (20%), amphetamines (22%), cocaine (19%) and
LSD (19%), while heroin was indicated relatively rarely. Regarding the distinction by groups it
became apparent that "ravers" have the strongest tendency to experiment with illegal drugs,
followed by youths in the "fun sports" scene. The greatest difference was found in the case of
ecstasy, which almost two thirds of the "raver" group reports to have used, compared to only
ten percent of the "fun sports" group, two percent of the young people organised in
associations and four percent of the control group. On the other hand, the figures for
cannabis are more or less equally high among "ravers" (82%) and "fun sports” group (76%)
and also high among the "association members" (46%) and in the control group (64%). How-
ever, the reports for use are markedly less frequent for all substances and most groups if the
respondents are asked to indicate consumption within the past three months. The only high
figures for this period of investigation concerned cannabis (between 72% among "ravers“ und
32% among "association members“) and, exclusively in the raver group, ecstasy and amphe-
tamines, with 42% each. As to legal substances, the figures for alcohol consumption were
high in all four groups, also when asked to indicate consumption within the past three months
(ravers 86%, fun sports activists 90%, association members and control group 92% each).
As underlined above, the study is not representative, so its results must be read with due
care and should not be used for generalising statements about drug use among youths. Still,
the study leads to some relevant conclusions: one is that it confirms that the consumption of
illegal drugs has strong correlations to lifestile variables, which is most evident in the drug
affinity of the raver scene. This is in line with the results of two scene-specific studies
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presented last year (cf. ÖBIG 1999a). Members of the fun sports group also used illegal
drugs to a relevant extent, but they did not tend to use drugs other than cannabis frequently
or extensively. Another aspect revealed by the study is the special significance of cannabis
throughout the groups, as all of them reported frequent consumption experience, so that
there is no correlation with specific youth culture influences. Thus hemp drugs have a special
position as the "illegal routine drug" for young people (Springer et al. 1999). The view of
drugs by young people also concurs with earlier scene-specific studies: youths who have not
come into contact with drugs usually have no realistic concept of the effects and the potential
hazards brought about by drugs, while youths who have used drugs have a clear-cut view of
drugs which is characterised by their positive or negative experience. Therefore the authors
of the study consider it necessary to take into account the (varying) state of information and
experience of youths in prevention work.
2.3 Problem drug use
In the past estimates for assessing the prevalence of problem drug use, i.e. frequent
consumption of "hard" drugs (especially opiates and cocaine) which often brings about
addiction, health problems and adverse social and legal consequences (cf. Chapters 3 and
4), were mostly based on consistency checks in Austria. In the year 1999 the Federal
Ministry of Science and Transport financed the first nationwide scientific study to estimate the
number of problem opiate users (Uhl and Seidler 2000), which at the same time was
conceived as a pilot study regarding its methodology. A 3-sample-capture-recapture method
was used for the estimate, with a result of 17,276 problem drug users registered over the
surveyed period between October 1994 and November 1995. Gender-specific estimates
show a distribution of 70% men versus 30% women and an age distribution of approximately
25% (age 15 to 24) versus 50% (age 25 to 34) and 25% (age 35 to 54), with slightly lower
total figures obtained by this procedure (cf. Table A4 of Annex B). To complement the
capture-recapture estimate, the truncated Poisson and multiplier methods were used. The
result of the truncated Poisson method is a nationwide estimate of 10,702 (according to the
Zeltermann procedure) or 10,378 (according to the Chao procedure). Using the multiplier
method with regard to drug-related deaths, the estimate is between 12,200 and 24,400
cases. It should be taken into account however that in the surveyed period the number of
drug-related deaths was very high in long-term comparison (cf. Table A5 of Annex B).
Combining all the estimates, the authors conclude that a prevalence rate between 15,000
and 20,000 problem opiate users in Austria, approximately half of them in Vienna, is
consistent. An update of the prevalence estimate for the years 1996 to 1999 is planned for
spring 2001.
The situation concerning problem drug use may be regarded as stable in almost all regions.
In Vienna social street workers have registered a decline in the number of young
"newcomers" entering the drug street scene, while the number of clients over 30 is rising
(Verein Wiener Sozialprojekte 2000b). However, currently there are no studies investigating
consumption patterns or consumer characteristics. According to experts, polydrug use and
intravenous use continue to be the prevalent modes of consumption. It should be noted,
however, that certain ways of addictive behaviour and certain consumer groups are socially
more "conspicuous" than others (cf. also Chapter 12). For this reason, the information mainly
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refers to problem drug users who are part of the "drug scene" and/or turn to drug help
services. There is some evidence that at least in Vienna, cocaine (cf. Chapter 12) is gaining
in importance within polydrug use, and that opiates are no longer solely consumed as heroin
but increasingly as morphine tablets (cf. e. g. Drogenkoordination Wien 2000). One example
is a study of the Vienna hospital connection service CONTACT (cf. also Chapter 9.2) on the
circumstances of overdosing, with in-depth interviews of 90 clients (Seidler 2000).
Approximately half of the respondents indicated several substances as "main drug" (52%
morphines, 42% heroin, 22% cocaine, 22% benzodiazepine, 13% substitution medicine, 27%
other substances). Morphine tablets were also named most frequently as the "hard drug"
consumed within the past 24 hours (42%) and they were consumed intravenously without
exception. 34% reported to have consumed heroin (74% intravenous use) and 24% said they
had taken cocaine (61% intravenous use, 50% intravenous use mixed with heroin). An
interesting result was that 32 percent of the youths surveyed (versus 13% of the adults)
stated they did not use drugs every day. As to the setting of drug consumption, more young
people report that they have company when they use drugs (63% versus 42% adults) and
that they use drugs in the public sphere (58% versus 38% adults). Furthermore, the study
revealed gender differences: women were found to have an earlier and greater awareness of
the problem of addiction than men. This is consistent with experience from other fields of
drug help according to which women show a greater readiness to turn to help offers (cf.
Drogenkoordination Wien 2000 and also Chapter 9.6).
17
3 Health consequences
3.1 Drug treatment demand
As there is no uniform client documentation system, only few data of limited interpretative
value is available in the field of treatment. Since spring 1999 a working group convoked by
the FMSSG for establishing a uniform documentation and reporting system has been active
in setting up and implementing documentation standards. The first step was to commission
the Austrian Health Institute with the organisation of a pilot project with the priority aim of
recording the organisational structure of drug help in Austria (cf. Chapter 9.3).
In the course of this pilot project for establishing a documentation and reporting system of the
Austrian drug help services, aggregated data on the clients was also collected. First results
have been obtained in the field of outpatient treatment. Out of a total of 128 outpatient ser-
vices for drug addicts known to and contacted by ÖBIG, 51 services supplied interprêtable
data to ÖBIG by the time of drawing up the present report. As to data quality, it should be
noted however that due to the aggregate nature of the data no distinction was made between
examinations according to the Narcotic Substances Act, counselling sessions and long-term
care/treatment, or between alcoholics and persons addicted to illegal substances (since
many services are open to both groups). Nor can double counts be excluded either per
service (if a client was readmitted within the same year) or between services (if a client
turned to several services within the same year).
The total data available refers to approximately 3,400 clients, of whom 21% only used alco-
hol, 29% used opiates (exclusively or in combination with other drugs), 20% consumed
cannabis exclusively. 37% of the clients were women, 63% were men. The proportion of
clients with opiate use problems was approximately the same for women and men.
However, it should be pointed out that for the above reasons no conclusion as to treatment
demand because of (illegal) drug problems may be drawn on the basis of this data. There-
fore, no further analysis according to sociodemographic variables was made. This is yet
another evidence of the urgent necessity for implementing a uniform client documentation
system of epidemiological data from the field of treatment in Austria.
National monitoring of substitution treatment is effected by the FMSSG and based on the
reports of doctors. Despite the fact that not all cases are reported or reports often come in
late (cf. ÖBIG 1999a), some broad insights may be gained as to the quantitative develop-
ment and the characteristics of clients. The increasing acceptance of, and resort to, this form
of treatment is reflected in the annually rising number of reports concerning persons currently
undergoing substitution treatment as well as the rising number of clients going in for
substitution treatment for the first time (cf. Figure 3.1).
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Figure 3.1: Development of annual registrations of persons currently undergoing substitution
treatment in Austria from 1990 to 1999, by first treatments and continued treatments
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The majority of persons registered as currently undergoing substitution treatment in 1999
were long-term drug addicts, as is shown by the high number of over 30 year-olds in the age
distribution. The gender distribution of the registered persons is approximately even in the
age group below 20, while in the older age groups the number of men is higher (age 25 to
29: ratio 1:2, over 34: 1: 3; cf. Figure 3.2).
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Figure 3.2: Distribution of persons currently registered for substitution treatment in Austria by age and
gender in 1999
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3.2 Drug-related mortality
Until 1994 the number of drug deaths rose sharply, followed by a decline until 1997. Over the
past three years the number of persons who died as a direct or indirect consequence of drug
consumption was found to have stabilised. In 1999 a total of 174 drug-related deaths was re-
gistered (cf. Figure 3.3 and Table A5 of Annex B).
According to the analysis according to kind of overdoses which was introduced in 1995 to
better account for polydrug use (cf. ÖBIG 1996), polydrug intoxication cases with narcotic
substances are rising (increase by 42% from 1998 to 1999). In contrast, the number of intoxi-
cation cases with only one narcotic substance involved continues to decline. The number of
drug-related deaths caused by AIDS, which had risen from nine to 20 cases from 1997 to
1998, fell again, to eleven cases (cf Figure 3.3 and Table A5 of Annex B).
Health consequences
20
Figure 3.1: Number of drug fatalities in Austria by cause of death from 1990 to 1999
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In 1999 the share of women among drug fatalities was 28 percent, which means that
compared to the preceding year (15%) the percentage has almost doubled. Another striking
result concerns the age group under 20, where women are strongly overrepresented (68%).
The number of men among drug fatalities, on the other hand, declined even in absolute
terms (1998: 138, 1999: 126). Looking at the gender distribution over the years, we find that
between 1990 and 1998 the percentage of women ranged from 15 to 21 percent (cf. Table
A7 of Annex B). Whether the increase in the share of women among drug fatalities in 1999
represents a trend or was just a one-time statistical outlier will remain to be seen in the
future.
More than half of the drug fatalities of 1999 concerned persons over 29 years (59%), 30
percent were aged between 20 and 29, eleven percent were under 20. The annual trend of
the past few years shows a slight increase in the age group over 29 (1993: 41%, 1995: 51%,
1998: 54%), which continued in 1999. In the age group under 20 the 1999 percentage (11%)
was above that of 1998 (5%) and approximately equal to that of 1997 (12%: cf. Figure 3.4
and Tables A7 and A8 of Annex B).
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Figure 3.2: Age distribution of drug fatalities in Austria from 1990 to 1999
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The development in the number of drug deaths varies noticeably between the provinces.
While in Vienna a rise of 30 percent compared to the preceding year was observed, the only
other provinces with an increase in drug fatalities were the Tyrol and Lower Austria. In all the
other provinces the number is constant or decreasing, and in Upper Austria even strongly
decreasing (cf. Tables A6 and A9 of Annex B).
In spring 2000 a study was published with the aim of examining the repeatedly encountered
hypothesis that the rising number of drug fatalities during the first half of the 1990s was
causally connected to the opening of the borders to the East and the (allegedly) resulting
dramatic changes of the heroin market (easy access to cheap, highly concentrated heroin, cf.
ÖBIG 1996). Laboratory tests of the heroin seized by the police in Vienna between 1987 and
1995 and an analysis of lethal overdoses in the same period yielded the following results:
within the surveyed period, there were no significant changes in the diacetylmorphine
concentration in the seized heroin, which had been intended for retail trade. Also, there was
no significant correlation between the diacetylmorphine concentration in the seized heroin
and the number of heroin overdoses. These results contradict the hypothesis mentioned
above. The authors attribute the increase in the number of drug fatalities during the first half
of the nineties to a significant rise in polydrug heroin use (i. e. heroin consumed in
combination with alcohol and other drugs; Risser et al. 2000).
A cohort study coordinated by the EMCDDA determining the mortality rate of all opiate
addicts in Vienna undergoing substitution treatment has yielded preliminary results. Since the
early nineties this rate has varied between 0.5 and 2.8 percent, and in the years 1997 and
1998 it was approximately one percent (Vicente et al. 2000).
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3.3 Drug-related morbidity
Especially for injecting drug users, infectious diseases represent a great threat to physical
health. While up to the first half of the nineties the risk of HIV infection was a central topic, in
the second half of the nineties the risk of hepatitis B and hepatitis C infection received
growing attention. On the whole the available data show a stable HIV prevalence rate at a
low level (between 0% and 3%). In contrast, the prevalence rates for hepatitis have been at a
very high level, with great variation of prevalence rates registered in the individual services
submitting data (hepatitis C: between 35% and 85%, hepatitis B: between 12% and 64%).
The topic of infectious diseases among drug users is treated at length in Key Issue Chapter
13.
Apart from infectious diseases, general medical care for drug users often poses problems
because of their lacking social integration. For this reason, the low-threshold services also
offer general medical care. The Vienna low-threshold facility Ganslwirt issued 6,319 medical
diagnoses in 1999, of which 35 percent concerned the diagnose "withdrawal symptom", 21
percent were diagnoses in the field of dermatology (e. g. abscesses), 16 percent belonged to
the field of psychiatry/neurology, 14 percent concerned general symptoms, twelve percent
were diagnoses in the field of internal medicine, and two percent were intoxications. An in-
creasing problem is posed by intravenous injection in the inguinal region, which tends to lead
to infections and serious complications (thromboses, embolism, sepsis; Verein Wiener So-
zialprojekte 2000a).
In Vienna the decline in the number of overdose cases that has been observed for many
years has continued. This also becomes apparent in the continuous decrease in the number
of ambulance services needed because of drug emergencies, from 705 cases in 1993 to 315
cases in 1999 (1998: 360).
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4 Social and legal correlates and consequences
4.1 Social problems
According to the drug help facilities, unemployment, lack of a secure housing situation and
high debts continue to be the main social problems of drug addicts. This becomes apparent
in some examples provided by the Vienna Social Projects Association: an evaluation of the
sleeping facility of the outpatient service Ganslwirt (cf. Chapter 9.4) showed that part of the
clients turn to this service because of prolonged homelessness rather than in acute situations
of crisis (Verein Wiener Sozialprojekte 2000a). Most of the clients of Streetwork were
unemployed (59% out of 771 persons; another 29% were in irregular employment situations)
and due to their lack of qualifications and the tense situation on the job market, they found it
difficult to be integrated into working life. The situation is especially dramatic in the case of
women working as prostitutes for the purpose of drug acquisition, because their social and
health problems are worsened by their "double stigma" and "double dependence" (on the
drug and on their drug-addicted partner; Verein Wiener Sozialprojekte 2000b).
In the course of cooperating with youth-specific services, Streetwork participated in a study
of a specific group of socially disadvantaged youths at a Vienna "scene location", where the
youth scene and drug scene mingle (AG SCHOP 1999). Drugs such as cannabis, heroin and
cocaine play a central role there, but injecting drug use is still rare. All of the youths come
from immigrant families and for the most part they are in a very instable social position. More
than half of the 40 respondents said they were unemployed or had only occasional jobs. In
addition, some of the youths have an insecure immigration status, which represents an
additional difficulty when trying to enter the job market. Almost all of the youths had some
form of experience with criminal prosecution. At the same time, they long for a "normal" life
with a secure income, a regular job, a family, daily routines and less drug problems. This
calls for intensive outreach work above all to assist the youths in tackling their social pro-
blems (cf. Chapter 9.6).
A diploma thesis on the role of drug addicts as victims (Waidner 1999) had interesting
results. By means of problem-centred interviews with a sample of 24 long-term opiate addicts
(17 men, 7 women, all of them imprisoned at the prison of Favoriten, Vienna), the experience
of drug addicts as targets of criminal acts and their behaviour as victims was analysed. All
the respondents said they had been targets of a criminal act at least once; men primarily
report to have been physically injured (58%) and threatened (12%), and women to have
suffered sexual abuse, rape and sexual coercion (100%) as well as theft (43%). It also turned
out that the persons concerned for the most part did not seek help and support from the
official prosecution authorities, which makes the offences against drug addicts imperceivable
by the public, and that criminal acts occurring in the subcultural sphere are often regarded as
"the price you pay" or as everyday incidents. The study reveals that drug addicts, who are
often perceived primarily as "offenders", in fact quite frequently become targets of criminal
offences.
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4.2 Drug offences and drug-related crime
The number of reports for violation of the Narcotic Substances Act (NSA) remained stable
compared to the preceding years and was 17,597 in 1999 (1998: 17,141; cf. also Table A11
of Annex B). A total of 17,211 reports referred to narcotic substances, the rest to psycho-
tropic substances. With regard to types of report (cf. Figure 4.1), a rise in reports for mis-
demeanours (possession and small-scale trafficking of drugs as regulated under Art. 27 of
the NSA) and a decline in reports for felonies (large-scale trafficking and commercial
trafficking as regulated under Art. 28 of the NSA) was registered, with the latter remaining
below 2,000 cases for the first time since 1992.
Figure 4.1: Development of reports to the police for violations of the Narcotic Drugs Act/Narcotic
Substances Act by misdemeanours and felonies in Austria from 1990 to 1999
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Note: The Narcotic Drugs Act was replaced by the Narcotic Substances Act on 1 January 1998. For better comparison, the
1998 and 1999 data in this figure indicate reports on account of narcotic drugs only. The difference to the total number of
reports results from reports that cannot be allocated.
Source: BMI (FMI) - Jahresberichte über die Suchtgiftkriminalität in Österreich
Regarding the substances involved, in 1999 again a marked rise of reports in connection with
cannabis was registered. Compared to the preceding year, the number of reports for cocaine
(cf. Chapter 12.3) and ecstasy rose, while there was a decline concerning opiates and LSD
(cf. Figure 4.2 and Table A13 of Annex B). A separate indication of amphetamines will only
be possible as of the year 2000. There are great regional differences regarding the
substances involved (cf. Table A14 of Annex B). In Vienna the proportion of reports in
connection with opiates is comparatively high, while the majority of reports in all other
provinces concern cannabis.
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Figure 4.2: Development of reports to the police for violations of the Narcotic Drugs Act/Narcotic
Substances Act in Austria by drug type from 1990 to 1999
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Note: The Narcotic Drugs Act was replaced by the Narcotic Substances Act on 1 January 1998.
Source: BMI (FMI) - Jahresberichte über die Suchtgiftkriminalität in Österreich
As explained in previous years, the data concerning reports to the police only allows for very
limited conclusions to be drawn as to the development of consumption and misuse of illegal
drugs, because they primarily reflect the intensity and focus of police activities in this field.
Compared to over 17,000 reports to the police in 1999, 1,864 arrests in connection with
narcotic drugs investigations were registered, but there are no details (type of offence,
substance involved, etc.) available for the latter.
In 1999 there were 3,359 convictions under the Narcotic Substances Act (leading offence; cf.
Note to Table A15 of Annex B), which is nearly the same level as the year before (3,327 in
1998). Again, there were dinstinctly more misdemeanours (Art. 27 of the NSA – possession
and small-scale trafficking), namely 2,230, compared to 1,022 felonies (Art. 28 of the NSA -
trafficking; cf. Table A15 of Annex B). Approximately 57 percent of all the persons convicted
were punished with imprisonment, 24 percent of the sentences were suspended and 33
percent were not suspended. There are clear distinctions made between youths and adults,
and between misdemeanours and felonies. Persons convicted for misdemeanours are often
sentenced to pay fines and rarely punished with unsuspended prison sentences, while
felonies often lead to unsuspended prison sentences. In general, youths are rarely ever
punished with imprisonment (cf. Table A17 of Annex B).
Complementary to the data on convictions, information concerning the preliminary
(provisional) withdrawal of reports to the police (Art. 35 of the NSA) and dismissal of pro-
ceedings (Art. 37 of the NSA) is also relevant. These legal alternatives to criminal pro-
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secution (cf. also Chapter 9.6) were made use of in 7,030 cases in 1999, which is a decline
for the first time in many years (1998: 7,468). The possibility of withdrawing reports in
connection with first offences for cannabis, which is facilitated under the NSA (Art. 35 par. 4),
was applied in 1,355 cases (1998: 1,432), which are included in the total number indicated
above. Currently there are no reliable data on the application of suspension of sentence
(under Art. 39 of the NSA –"Therapy instead of punishment“).
For the reporting period no data or studies on crimes committed for the purpose of drug
acquisition or other drug-related crimes or on the prevalence of drug users in prisons are
available.
4.3 Social and economic costs of drug consumption
So far there hardly any studies on the social and economic costs or drug consumption in
Austria are available. In 1999 the first comprehensive study on economic aspects of drugs
was carried out, which focused on an estimate of the expenses in various spheres (cf.
Chapter 1.4 and Table A1 of Annex B). It also includes an estimate of drug-related costs
incurred in the sphere of hospitals in connection with drugs. In 1997 3,574 patients received
inpatient treatment for a total of 63,341 days, which represents a total expenditure for the
treatment of drug addicts of ATS 213.2 million (approximately EUR 15.5 million). For this
estimate only diagnoses that were directly drug-related were taken into account.
Approximately ATS 480 million (approximately EUR 35 million) go into care and treatment by
the drug help facilities.
Another study (Mazegger 1999) had the aim to give an estimate of the economic influence of
drug consumption and trafficking on the gross national product. Based on the available
information on the amount of substances seized, the market and street prices, the
prevalence of drug consumption and consumption patterns, a calculation of the economic
value of supply (varying between ATS 539 and 2,559 million, or between EUR 39 and 186
million, according to the basic assumptions) and demand (ATS 4,377 million, or EUR 318
million) regarding illegal drugs was attempted. On this basis the resulting added value
relating to the traffic with illegal drugs would be ATS 3,160 million (230 million EURO) or 0.13
percent of the gross national product in 1997. However, the author points out that the
calculation is based on many assumptions, so the results should be regarded with caution.
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5 Availability and supply of drugs
According to the Federal Ministry of the Interior (FMI) the trends concerning the situation of
organised narcotic drug trafficking remained basically unchanged in 1999 (Bundesministe-
rium für Inneres 2000). As in the preceding year FMI data suggests an increase of ecstasy
trafficking and consumption and a further spreading of this problem to small-scale events and
discos. Furthermore, an increase in smuggling, trafficking and use of amphetamines was re-
gistered, which, however, could not be indicated separately in the 1999 statistics.
Regarding the development of seizures over the past four years there was a decline in
heroin and LSD seizures; cocaine and ecstasy seizures remained stable, and cannabis
seizures rose slightly (cf. Table A18 of Annex B and Figure 5.1).
Figure 5.1: Number of seizures of narcotic drugs in Austria from 1990 to 1999
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Source: BMI (FMI) - Jahresberichte über die Suchtgiftkriminalität in Österreich
The amount of substances seized reflects these trends only to a limited extent, as they are
strongly influenced by individual seizures of exceptionally large quantities (cf. Table A19 of
Annex B). To give an example, the number of cannabis seizures rose from 4,683 (1998) to
5,079 (1999) while the total amount of substances seized declined from 1,336 kg (1998) to
451 kg (1999).
The ChEck iT! project in Vienna, which offers on-the-spot testing of the purity and contents
of tablets bought at rave parties under the name of ecstasy, continues to be the most
relevant source of data and information on synthetic drugs (cf. also Chapters 9.1 and 9.2).
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The results of analyses carried out in autumn 1999 at five events demonstrate that the pro-
portion of "ecstasy tablets" which actually contained MDMA was significantly higher than in
the previous years (cf. Kriener et al. 1999). This development was confirmed by the analysis
of 86 tablets bought under the name of ecstasy carried out by ChEck iT! at a rave event in
Vienna on 1 July 2000. The share of actual ecstasy (MDMA) was 87 percent, which is
comparatively high. Less than 20 percent of all tablets (also) contained ingredients other than
MDMA (MDE: 4 tablets, MBDB: 3 tablets, amphetamine or metamphetamine: 4 tablets,
caffeine: 1 tablet, unidentified substance: 1 tablet and pain killers: 3 tablets). The MDMA
content of the analysed ecstasy tablets varied between 30 mg and 110 mg. However, the
data only refers to individual events, so it should not be taken as a basis for assumptions of a
general trend. One result that should be pointed out is the fact that the design of the tablets
permits no conclusions as to its contents, as tablets with identical logos frequently have
differing chemical components.
Capsules and powder bought as speed, metamphetamine or amphetamine (17 samples) and
analysed at the same event in July 2000 all contained the corresponding substances. Three
samples additionally contained caffeine, and in one sample, an additional unidentified
substance was found.
In July 2000 the substance PMA was found in tablets offered under the name of ecstasy for
the first time in Austria. An amphetamine derivative like MDMA, PMA is much more
dangerous because of its higher toxicity and delayed effect (which tempts consumers to take
more and more tablets). The consumption of PMA mistaken for "ecstasy" led to a death case
in Lower Austria in July 2000. In a police raid on this occasion, 4,500 tablets containing PMA
were seized. The tablets displayed the so-called "Mitsubishi“ logo, which is frequently found
on ecstasy tablets.
No results of the project "Spritzencheck“ (syringe check), which has analysed the residues in
used syringes in order to obtain evidence on the purity of the injected substances, are
available yet, but they are expected for the second half of 2000.
As no new studies regarding the prices of drugs were drawn up in the reporting period,
reference is made to last year's data in this context (cf. ÖBIG 1999a; regarding cocaine see
also Chapter 12.3 of the present report).
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6 Trends per drug
Cannabis is the illegal substance which is by far most frequently used. Studies in this field
have shown that up to one third of the young adult population have experience of cannabis.
In specific youth scenes characterised by high drug affinity, the proportion is even higher.
However, regular use of cannabis is much less frequent than experimental consumption. As
before, reports on social or health problems in connection with cannabis use are rare.
Cannabis is also the substance to which the majority of reports to the police and seizures
refer, in accordance with a rising trend that has been going on for years in this respect.
Synthetic drugs, above all ecstasy (MDMA), are the second-most consumed illegal drugs
after cannabis, and are especially popular among youths. According to various studies,
approximately four percent of the youths state to have consumed synthetic drugs. During the
past few years the figures for ecstasy have stabilised, while use of amphetamines seems to
be rising, for which there are no reliable data sources at present, however.  Especially in the
rave scene, high figures of ecstasy and amphetamine use are registered. Tests of the
substances have shown that the tablets sold as "ecstasy" quite frequently fail to contain pure
MDMA. In summer 2000 tablets containing PMA appeared on the Austrian market for the first
time which led to a death case. In contrast, so far hardly any social or health problems have
been observed in connection with ecstasy (MDMA).
In representative studies opiates have been found to be used by no more than one percent
of the respondents. However, opiates are the most relevant group of substances when it
comes to problem drug use. Nationwide, the number of problem opiate users is estimated to
lie approximately between 15,000 and 20,000, with a majority following polydrug use patterns
(cf. below). All over Austria the opiate problem is considered to be stable or even decreasing.
As data for Vienna has shown, beside heroin, addicts are increasingly consuming morphine
tablets, which is attributed to an increased supply in the illegal market. In almost all cases of
drug intoxication opiates are found, but drug fatalities are increasingly caused by mixed
intoxications rather than by opiates alone. The number of reports to the police and seizures
have been declining for some years.
Similarly, use of cocaine (cf. Chapter 12) has been registered in between one and two
percent of the population at the most, with a slightly rising trend. Due to falling prices and
easy availabilty, cocaine has become more relevant in the open drug scene, where injecting
use as a component of polydrug consumption (cf. above) is frequent. However, hardly any
fatalities have been registered where cocaine was (also) found to have played a relevant
role. In the last few years a rising trend regarding the number of reports to the police and
seizures in connection with cocaine has been observed. Crack has not been relevant in
Austria so far.
As discussed above, polydrug use is the predominant mode of drug consumption among
drug addicts in Austria. Recently, cocaine and – at least in Vienna – morphine tablets (see
above) have gained importance in multiple and mixed drug use involving various substances
(such as heroin, benzodiazepines, alcohol). Most of the substances are injected, sometimes
also in combinations. This is also reflected in the health consequences: the number of drug
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fatalities caused by mixed intoxication has sharply risen in recent years, with the total
number of drug-related deaths remaining stable. Furthermore, social problems such as
unemployment, homelessness and high debts are encountered frequently in this group of
drug users.
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7 Discussion
The data available on the epidemiological situation in Austria are in line with the trends of
previous years. Regarding problematic consumption of illegal drugs, especially opiates, a
stable situation is observed on a nationwide scale. The fact that the number of opiate users
undergoing substitution treatment has risen is due to the rising acceptance of this form of
treatment rather than to a rising number of problem opiate users. Apart from these data there
is hardly any conclusive evidence regarding the field of treatment. Despite ongoing police
activities in this field, the number of reports to the police and seizures of opiates have
continued their downward trend. The number of drug-related deaths rose slightly, but has
remained on the level of the last three years, which is clearly below the figures for the mid-
nineties.
Data for all other substances stems mainly from consumption studies or police information.
The consumption studies indicate stable figures regarding lifetime experience in the total
population. Representative youth studies show rising figures for cannabis use, but hardly any
increments of the use of any other drug. A recent study on various "youth scenes" confirms
the results of earlier "scene studies" indicating that specific youth cultures, especially the
rave culture, have a high drug affinity. As to reports to the police and seizures, the
development has been contradictory. Only in the case of cannabis have the corresponding
figures risen over the past few years. Reports to the police in connection with cocaine and
ecstasy increased slightly compared to the preceding years, but the figures remained below
the 1997 level.
The high drug affinity of specific youth cultures represents a great challenge for drug policy,
which has already led to the development of new strategies especially in the field of
secondary prevention. How to reach and counsel youths endangered by drugs through
creating target group oriented services remains an important issue. Regarding "traditional"
forms of problem drug use, especially opiate use and polydrug consumption patterns, the
existing measures appear to serve their purpose; what is necessary in this field is the further
expansion of the services offered, especially by closing regional gaps.
Because of the deficits in the Austrian monitoring system, a comprehensive analysis of the
epidemiological situation and the trends is possible only to a limited extent. In particular, the
field of drug-specific treatment and care and consumption studies carried out at regular
intervals for long-term comparison is lacking conclusive data comparable at the national
level. Therefore these are two priority fields for the further development of the monitoring
system. Complementary to routine data, studies on a smaller scale that examine specific
problems often yield important information. Although they are not representative in many
cases, still they permit profound insights into the drug situation. Data from police sources, on
the other hand, only permits very limited conclusions on the epidemiological situation, as it
primarily reflects the police activities in the respective field.
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8 Strategies in demand reduction at national level
8.1. Major strategies and activities
In the reporting period three provinces adopted drug plans, all of which focus on health and
social policy measures and thus on the field of demand reduction (cf. also Chapter 1.1). The
drug plan of the province of Salzburg, drawn up in 1999, places special emphasis on creating
a drug help system based on systemic and integrative principles and oriented towards
concrete needs. The Styrian drug plan of 1999 also stresses the aim of creating a dense
network of various therapy modules that include outreach work as well as low and high
threshold services. In this way changing motivations in the course of year-long addiction
processes may be taken into account. The drug plan of Lower Austria has the basic aim to
provide a framework for the whole range of addiction-related activities and thus includes both
legal and illegal substances. In the drug plans of the other provinces (cf. Chapter 11.1.2) the
importance of comprehensive approaches is also emphasised, although they focus on illegal
drugs only, which is explained by the need for specific solution strategies. However, this
does not apply to the field of primary prevention, which continues to be based on a broad
concept of addiction and for which comprehensive strategies based on health promotion are
developed.
The drug plans of the individual provinces are in line with the prevailing drug policy principles
described in greater detail in Chapter 11. Regarding demand reduction special emphasis has
been placed on the central prerequisite that drug help activities should be oriented towards
concrete needs and that multidisciplinary, coordinated strategies should be adopted (cf.
Chapter 11.1.2). In addition the subject of quality standards for drug work is raised more and
more often. For instance, when the Federal Ministry for Social Security and Generations
(FMSSG) drew up guidelines for the announcement of drug facilities according to Art. 15 of
the NSA special importance was attached to the aspects of quality assurance and minimum
standards for recognition. A number of other provinces also plan to define and implement
guidelines for the quality assurance of drug work (cf. also Chapter 10).
It is still the provinces that provide most of the funding for social and health policy measures
in the field of drugs. While budgetary economies embarked upon at the federal level have led
to a reduction of resources also for drug-related activities (cf. Chapter 1.4) a number of pro-
vinces plan to expand this field further. For instance, the Province of Lower Austria has
increased the resources of the year 2000 (ATS 23.3 mill. or EUR 1.7 mill.) by 13 percent
compared to the year before. Still, the available funds for demand reduction interventions
generally seem to decrease also at the provincial level. Additional resources, especially for
the field of prevention, may be obtained from the Healthy Austria Fund (HAF). In the
reporting period a number of projects and activities – including quality assurance measures –
were cofinanced by the HAF (cf. also Chapter 10).
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8.2 Approaches and new developments
Regarding concrete measures of demand reduction (cf. Chapter 9) above all the existing
approaches have been further developed, with some new focuses. In the field of prevention
the workplace has become a more important setting – in almost all provinces projects of
addiction prevention at the workplace are being run (cf. Chapter 9.6). The expansion of
secondary prevention structures (cf. ÖBIG 1999a) continues to play a prominent role, and
many regions plan to establish or further develop outreach structures and low-threshold
services (cf. Chapter 9.2).
The trend towards a regionalisation of relevant facilities emerging in the past few years still
continues, and its effects are becoming more and more obvious not only in the field of pre-
vention but in the whole area of drug help. European cooperation projects also continue to
play a central role. For example the Viennese drug facility DIALOG cooperates with partners
in Germany and the Netherlands in the context of the project “Addiction as a chance of
survival for women with experience of violence” planned to be carried out within the frame-
work of the Daphne Programme of the EU (cf. Chapter 9.6). In the Tyrol the prevention
centre kontakt&co coordinates a European project on early detection of problem situations
and crisis intervention, for which an instruction CD-ROM with links the Internet are also used.
New media are generally used more and more often to provide information and carry out
prevention work. An increasing number of drug facilities have their own web sites for the
purpose of an exchange of information among experts and also for “persons concerned” (cf.
also Chapter 9.1). In the reporting period a number of new booklets were also published: e.g.
the Addiction Prevention Units, cofunded by the FMSSG, edited the booklet “sucht & drogen.
nüchtern betrachtet” [addiction & drugs considered soberly], aimed at presenting hard facts
on drugs to contrast them with existing prejudices and stereotypes.
In the whole field of demand reduction the aspect of quality assurance is rapidly gaining in
importance. An increasing number of projects are evaluated, quality guidelines are defined,
and education and training measures for drug experts and other groups concerned with the
problem of drugs are intensified, and research activities are carried out for planning,
accompanying and evaluating projects (cf. Chapter 10).
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9 Intervention areas
In the following chapter examples of different measures taken in the field of demand
reduction in Austria are presented. The list does not claim to be exhaustive. The central
focus was placed on new activities as well as projects and measures for which evaluation
results are available. More detailed descriptions of individual projects and measures of
demand reduction are found both in the reports of the last few years (ÖBIG 1997, 1998,
1999a) and in the EDDRA database of the EMCDDA (cf. list of Austrian EDDRA projects in
the reference section). In addition the maps presented in the Annex (cf. Maps 2 and 3 of
Annex B) provide an overview of the regional distribution of drug facilities and drug help
services.
9.1 Primary prevention
In Austria special importance has been attached to prevention measures for many years
already. In the beginning the central focus was placed on primary prevention, but recently
secondary prevention measures have also been intensified (cf. ÖBIG 1999a). Primary
prevention (addiction prevention) is aimed at precluding addiction already at its roots. Its
target group is persons who do not belong to a specific at-risk group and who have not had
addiction problems so far. Interventions in this field often follow the principle of health
promotion and primarily address children and young persons. Secondary prevention (drug
prevention), on the other hand, is oriented towards defined at-risk groups and persons who
do have addiction problems although they have not become manifest to their full extent (cf.
also ÖBIG 1999b). The target group of secondary prevention measures mainly comprises
young persons.
Most of the preventive measures are implemented at the local and/or regional levels. In this
context the Addiction Prevention Units at provincial level play an important role (cf. Figure A1
of Annex B). The Units are responsible for initiating preventive measures and providing
professional approaches as well as quality assurance. In Austria a broad range of preventive
measures are found in many different fields, so in the following only a few projects will be
presented as examples (cf. also Chapter 9.6).
Primary prevention already starts in early childhood, based on activities in the infancy and
family area. In this context kindergartens play a prominent role. In the past few years several
provinces carried out the project “toy-free kindergarten”. The evaluation of the Viennese
project has shown that the objectives of the project could be met (cf. ÖBIG 1999a and
EDDRA). In Burgenland the project was carried out in a total number of nine kindergartens in
2000, and in some kindergartens it has formed an integral part of their programmes. The
project “Parents as Peers”, which has been started in Upper Austria, is directly aimed at
parents. It is an international cooperation project with the target group of parents who cannot
be reached by means of traditional education.
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In order to ensure the sustainability of the measures aimed at preventing addiction, further
training schemes have also been organised in this field. In Styria the Addiction Prevention
Unit VIVID ran the further training programme “Addiction Prevention during Childhood”,
addressing kindergarten teachers. As was shown by the evaluation the participants were
able to integrate the knowledge obtained about primary prevention in their practical work (cf.
also EDDRA). In Burgenland further training schemes specifically oriented towards teachers
at the Federal Kindergarten Education Institute at Oberwart as well as students in their final
year were started.
School programmes continue to be the most important setting for interventions aimed at
preventing addiction. In the context of the educational principle “health education” primary
prevention has to be integrated in all subjects. In the last few years such activities have more
and more often been started already at the primary school level. For instance, in Lower
Austria the project “It’s Victoria’s Birthday” was carried out, where children could present their
own experience in the context of an animation theatre play. In this way the children are
taught to identify the opportunities and risks of this stage in life so that they may develop
adequate responses.
Further training plays a prominent role in this field as well. As of autumn 2000 the Federal
Teacher Training Academy of Upper Austria will start a study course on addiction prevention
for teachers, with the aim of training addiction prevention coordinators at schools. In Vienna
the Information Centre on Addiction Prevention organised a further training programme for
lower secondary school teachers of the 10th district of Vienna, under the motto “regional
addiction prevention at lower secondary schools”. Prevention experts, in cooperation with the
teachers, defined possible aims of structural and individual interventions at the schools of the
district.
The interactive computer programme “Step by Step”, an up-to-date training tool for teachers,
focuses more strongly on secondary prevention. It was developed by prevention experts in
the context of a European project (cf. Chapter 8.2) coordinated by the Tyrolean Prevention
Unit kontakt&co. The programme is oriented towards early detection and intervention at
schools and may be used for identifying, and competently responding to, possible signs of
addiction among pupils at an early stage (cf. also EDDRA). The use of this CD-ROM is also
supported by the Federal Ministry of Education, Science and Culture (FMESC).
Regarding youth programmes outside schools it has been planned to intensify the coope-
ration between the youth department, which has become part of the FMSSG now, and the
Addiction Prevention Units. In addition the Austrian Education Forum for Promotional and
Preventive Youth Work (cf. ÖBIG 1999a), which is funded by the Youth Department and the
Provinces, plays a central role, especially in the field of quality development and lobbying in
all fields of prevention relevant for youth work (addiction, AIDS, violence, etc.), and it also or-
ganises a broad range of further training events.
There are many different services for young people in the fields both of primary and secon-
dary prevention. For instance in Mödling, Lower Austria, a low-threshold meeting place for
young people has been run for several years now. Its aim is to strengthen life skills, self-con-
fidence, creative expression, the ability to establish relationships etc. of the young people
through projects in the context of primary and secondary prevention, organised in the
Intervention areas
39
meeting place itself and at schools. The WAGGON centre was established when problems
concerning misuse of alcohol, pharmaceutical drugs and cannabis arose around the railway
station at Mödling, where thousands of pupils leave for school and return to their homes (cf.
also EDDRA).
In addition the existing activities explicitly aimed at secondary prevention for youths were
continued (cf. also Chapter 9.2). At present a study course for social workers at official youth
welfare departments and independent youth welfare organisations is being run in Carinthia in
order to provide a network for young persons in danger of addiction, run by qualified experts
and covering the whole province. In spring the Youth and Family Offices of Vienna
established the Competence Centre Drug Work, which provides expert information on drugs
for employees (especially of crisis intervention centres) as well as the necessary communica-
tion structures between facilities for young persons in general and specific drug facilities.
Compared to other intervention fields, there is only a limited number of community
programmes for addiction prevention. One example is a community-oriented, systemic pro-
ject that has been run for more than four years in the town of Trofaiach, Styria, and its
surroundings. When a few heroin-related fatalities occurred, a contact point was established.
Its main activities are providing behavioural and structural intervention strategies in the fields
of primary and secondary prevention. The office also supports the work of a large group of
key persons and inhabitants of Trofaiach dealing with the problem of preventing addiction
and also intensively cooperating in the development of the project. Another key group in the
implementation of the project is young residents of Trofaiach who work as peer educators
both in and outside schools.
The telephone help lines that have been run for quite some time in the provinces of Vorarl-
berg and Vienna have now been complemented by a service of the Provincial Neurology
Hospital at Gugging, Lower Austria, where telephone support as well as emergency and cri-
sis intervention are provided around the clock.
Mass media campaigns for the purpose of prevention continue to play only a minor role in
Austria. No such activities took place in the reporting year.
As has already been mentioned, new media and especially the Internet have played an
increasingly important role in the field of prevention. By now the majority of the regional
Addiction Prevention Units have created their own web sites. The Province of Lower Austria
plans to establish an Internet counselling service before the end of this year. The ChEck iT!
activities (cf. also Chapter 9.2) have also been complemented by an information service on
the Internet. The homepage www.CheckYourDrugs.at provides detailed information on psy-
choactive substances, their chemical activity, negative and possible long-term effects, advice
with regard to multiple drug use and ways of risk minimisation. This information is updated at
regular intervals so that new results of scientific research may be incorporated. In this way
warnings, e.g. about PMA (cf. Chapter 5), may also be communicated quickly.
9.2 Reduction of drug-related harm
There is a broad range of interventions aimed at reducing drug-related harm that address
drug users or drug addicts. Most of these measures are not primarily oriented towards
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abstinence; but rather their aim is to provide low-threshold assistance for drug addicts in their
actual life situation and reduce the risks and problematic consequences of drug consumption
as far as possible. Therefore the corresponding measures are often referred to as “accepting
drug assistance”, “survival assistance” or “harm reduction”. Today they form an integral part
of the system of drug help in Austria (cf. Maps 2 and 3 of Annex B). For instance, on pre-
paring the guidelines for the recognition of facilities according to Art. 15 of the NSA it was un-
animously agreed that low-threshold services also meet the requirement of “orientation
towards abstinence”, as they stabilise their clients and thus increase the probability of
abstinence at a later point in time.
Outreach work is another important service provided in this field. In Austria the activities of
street workers have firmly been established in the drug scene for quite some time. There is a
great variety of forms of outreach work to assist drug addicts (outreach activities, mobile
units for first contacts etc.) and services focussing on specific target groups (e.g. prostitutes
working for the purpose of drug acquisition, prison inmates). In May 2000 the Viennese
hospital connection service for drug addicts (CONTACT), organised a symposium to
celebrate its fifth anniversary. From 1995 to 1999 CONTACT provided assistance to almost
1,300 persons – nearly half of them women (43%), and more than 5,000 clients contacted
this facility. About half of the total number of approximately 1,500 persons turning to
CONTACT for the first time had acute symptoms (emergency admission to hospital), and the
rest of the clients came from inpatient departments (internal medicine or gynaecological
departments etc.). At the initial stage CONTACT mostly dealt with overdoses, but as the
number of overdose patients was declining in the course of time care of drug addicts
admitted to hospital for other reasons has become more and more important (cf. also
Chapter 2.3).
In the last few years outreach social work has increasingly covered secondary prevention as
well. The relevant services frequently focus on social work for young persons in general, and
any drug problems that occur are dealt with in this context. This corresponds to the
experience that problematic patterns of drug use among young people are often
accompanied by acute social problems or crises (cf. also Chapter 4.1). Outreach services
were also provided as a response to the high affinity to drugs among ravers (cf. Chapter 2.2).
The Viennese project ChEck iT! (cf. also Chapter 9.1) offers social work during rave events,
combined with testing of synthetic drugs. In the Tyrol employees of the project MDI...B are
also present at raves, with the aim of reducing harm and providing secondary prevention. In
autumn 1999 the two projects cooperated when ChEck iT! offered drug tests during an event
in the Tyrol.
Almost all Provinces plan to establish or expand low threshold services. In Linz, Upper
Austria, a contact point for drug addicts will be organised, where medical care, practical
survival assistance, services providing daily structures as well as counselling and care will be
available. This will be combined with streetwork services for young persons in danger of
becoming addicted. The new provincial drug plans (of Lower Austria, Salzburg and Styria)
also include the establishment of low-threshold services, although some of them will be
implemented in the long run only. In the Tyrol the realisation of the project NIKA (cf. ÖBIG
1999a), which should also provide “health rooms” for injecting drug use, has been delayed. A
final political decision regarding its implementation is due in autumn 2000. Vienna plans to
Intervention areas
41
establish a temporary sleeping facility for children and adolescents offering individual
assistance to persons in crisis situations.
A large number of clients have turned to the low-threshold facilities that have existed for
some time now, which shows that such services are very well accepted. In 1999 the Gansl-
wirt facility in Vienna registered a daily average of 45 clients in the day centre and 25 con-
tacts to patients in the outpatient clinic, which results in an annual total of 16,000 clients, or
more than 9,000 contacts to patients per year. The outpatient clinic was very well frequented
– by up to 50 clients – especially during weekends, when no alternative services were
available. Altogether more than 1,200 different persons received outpatient care (Verein
Wiener Sozialprojekte 2000a). In 1999 the H.I.O.B. facility of Vorarlberg registered a total
number of 11,219 calls of approximately 350 clients, 531 medical consultations for 126
clients, and 83 clients receiving psychosocial counselling (cf. also EDDRA). Regarding the
gender of the clients of both facilities, women are “overrepresented” in the services offering
intensive counselling and care, compared to the percentage of women among the visitors of
the facility in general (cf. also Chapter 2.3).
The prevention of infectious diseases continues to be a relevant focus of services aimed
at harm reduction. In all provinces the corresponding services are being expanded. In spring
2000 the National Health Board, where guidelines for public health are discussed and drawn
up, dealt with the issue of “hepatitis and drug use”. In the next few months a working group
specifically nominated for this purpose will draw up a comprehensive plan for measures in
this field. Chapter 13.3 gives a more detailed overview of the range of services and
measures in the context of infectious diseases among drug users.
9.3 Treatment
By now Austria has reached almost nation-wide coverage regarding facilities for drug-related
counselling, care and treatment (cf. Map 2 of Annex B), although they are very different as to
size and specific focuses. The necessary services are provided both by specialised facilities
and in the framework of general health care (e.g. by psychiatric hospitals, psychosocial
service centres etc.). At present further information on the structure of drug help with regard
to target groups, availability and staff are being gathered in the context of a pilot project
carried out by ÖBIG on behalf of the FMSSG (cf. also Chapter 3.1). The first results will be
available by the end of this year.
In the reporting period no new facilities were established in this field, but a number of
Provinces have plans for relevant expansions. Regarding inpatient services the trend
towards short-term therapy has continued (cf. ÖBIG 1999a). The most important projects
planned in the field of therapy are the establishment of outpatient services for addicted
patients at seven Lower Austrian hospitals with psychiatric departments and the creation of
at least one central “crisis intervention facility” for addicted patients. In the long run “satellite”
low-threshold special services will be affiliated to existing outpatient departments. Carinthia
plans to establish a drug or substitution outpatient department at the drug counselling centre
of the Klagenfurt Municipal Corporation. This, as well as the creation of an inpatient drug
department for ten patients, is recommended in the psychiatry plan of Carinthia, which will be
presented in autumn 2000. In the Tyrol further steps towards the establishment of a second
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drug outpatient department were planned in the context of the regionalisation of drug
policies. The drug plan of Salzburg includes the organisation of compact therapies. In Styria
the preparatory activities for the three-month compact therapy model “Walk About” (cf. ÖBIG
1998) have begun, and implementation is planned as soon as possible.
The general conditions for substitution and maintenance programmes, which have been
described as a focal theme in the report of last year (ÖBIG 1999a), have not changed
significantly. The working group dealing with the reform of the Substitution Decree (cf. ÖBIG
1999a) finished its work in summer 2000. The results obtained will form the basis of an
adapted draft.
Since 1996 the substitution substance buprenorphine has been used in the context of
controlled studies and application observations at the outpatient drug department of the
General Hospital of Vienna (Drogenambulanz 2000) and has been administered primarily to
pregnant addicts (cf. also Chapter 9.6). In June 1999 buprenorphine was registered as a
pharmaceutical for the treatment of opiate addiction in Austria and has already been
prescribed frequently: in the Tyrol 20 percent of the substitution patients were treated with
buprenorphine in 1999.
In November 1999 a survey on substitution treatment was conducted among doctors in
Carinthia. Almost half of the participating doctors were in favour of transferring substitution
patients to specialised facilities for treatment, which is very time-consuming. So in the me-
dium run it would be advisable to establish a drug outpatient department to cover at least the
central area of Carinthia (cf. also above).
9.4 Aftercare and reintegration
Interventions aimed at aftercare and reintegration of (former) drug addicts address both
clients after abstinence therapy and persons who are currently addicted, in order to achieve
social stabilisation and reintegration. General aftercare measures (e.g. psychotherapy or
counselling by social workers) are provided by many drug help facilities (cf. also Chapter
9.3). In addition there are specific social reintegration services in the fields of education,
occupation and housing (see also ÖBIG 1998, ÖBIG 1999a).
Education and training schemes are frequently implemented in the context of inpatient
therapy. They often include activities aimed at reintegration into the labour market, as in the
case of the low-threshold occupation project WALD in the province of Vorarlberg and the
Vienna Job Exchange. The goals of WALD are to develop the ability to work of the
participants and to motivate them to cooperate in a work process. So far a total number of 83
persons have taken part in the project. 19 of them found jobs afterwards, 11 decided in
favour of a health-related measure and two changed to a higher-threshold work project (cf.
also EDDRA).
The Vienna Job Exchange, a facility of the Public Employment Service of Vienna, provides
labour market counselling services aimed at the occupational rehabilitation and integration of
persons with addiction experience. It is a link between the institutions responsible for the
care of addicted patients and the offices of the Public Employment Service (cf. ÖBIG 1998).
Every year approx. 1,000 clients turn to the Exchange, with the relation between men and
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women remaining almost constant over the years (roughly 70:30). The majority of the clients
had been unemployed between three and nine years before they received counselling by the
Vienna Job Exchange. In 1999 about one third of the clients could be referred to a job or a
training course to obtain further qualifications (cf. also EDDRA).
The socioeconomic project “fix & fertig” of the Vienna Social Projects Association (cf. ÖBIG
1999a), existing since 1995, offers employment on a daily basis or transition jobs for
persons who still take drugs, former drug addicts and clients of substitution programmes. The
project activities include counselling by social workers to assist reintegration in the general
labour market. In 1999 175 persons were employed on a daily basis. 20 transition workers
participated in the whole programme, and for 20% of them jobs in the general labour market
were found. Another 20% were assessed as job-ready or participated in additional education
and training schemes. More than one third changed to a therapy schemes. As the demand
for jobs on a daily basis by far exceeds the available jobs a further expansion of the project
would be possible, and also necessary (cf. also EDDRA).
The “Assisted Housing” project in Vienna provides temporary accommodation accompanied
by outpatient psychosocial counselling to help the clients “learn how to settle in”. The
available interim results confirm the success of this strategy: the majority of the clients
mastered this way of living and could be referred to a long-term flat. However intensive
counselling is needed to achieve this. Most of the total of 12 clients who have finished the
counselling stage so far have also improved their situation with regard to wage-earning,
debts and drug use (cf. also EDDRA).
The facility Ganslwirt, also situated in Vienna, evaluated its sleeping facility as it seemed to
be difficult to refer clients to long-term flats. The sleeping facility may be used for spending
the night in an emergency situation, and in 1999 it was used by 321 different persons (cf.
Chapter 4.1). One result of the analysis was that in most of the cases the clients had not
spent the night at Ganslwirt because of acute physical or psychological crises. In most cases
the reasons were long-term homelessness or that the clients could not get in a regular
habitation because of their drug use. So it would be important to increase the number of
assisted housing flats for persons with drug problems in order to provide medium-term
accommodation for homeless addicts. It has also been suggested to establish a competence
centre dealing with drug use and assistance for homeless persons within the Ganslwirt
facility.
In the drug plan of Lower Austria the expansion of accommodation facilities is also planned.
On the one hand assisted housing communities will be established for young persons, where
small flats will also be available for youths who have to fulfil court orders under the NSA, and
on the other hand housing communities with part-time counselling for adults will be provided.
9.5 Interventions in the criminal justice system
The drug-related prevention and treatment interventions in the criminal justice system were
further expanded (cf. also Map 2 of Annex B). A drug-free zone has been established in the
Dornbirn branch of the prison of Feldkirch, Vorarlberg, as well. At present similar approaches
may be found in almost all regions. In the reporting period an external evaluation of the pilot
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project of the prison of Hirtenberg, Lower Austria, which has been going on since 1995
already, was carried out, and the results will be available in autumn 2000. The running docu-
mentation shows that between 1995 and 1999 a total number of 791 prisoners lived in the
drug-free zone. 18 percent left the programme prematurely: 7.7 percent because of positive
urinalyses, 6.7 for disciplinary reasons and 3.7 percent because they had abused privileges
(cf. also EDDRA). In the prison of Stein a ward with 42 beds for substitution treatment was
established. The Federal Ministry of Justice (FMJ) is preparing a booklet describing the
manifold activities in the field of drug-related demand reduction in the criminal justice system.
It will be published at the end of the year 2000.
Since 1999 the drug counselling facility “Dialog” has medically treated drug-addicts detained
in the police prison of Vienna. This approach has been very successful. Both the clients and
the public health officers, first-aid attendants and officers of the police prison gave a positive
feedback. In 1999 a total number of 463 patients were treated, with the focus placed on
substitution therapy. In addition withdrawal symptoms and psychiatric problems were also
treated medically. At the beginning of 2000 the service was expanded: as of this time doctors
may be contacted in the facility five days a week instead of three (Dialog 2000).
The police continue their activities in the field of prevention, and endeavours to assure the
quality of their interventions are made. The criminal police information service of Vienna pre-
pared guidelines for addiction prevention by police officers based on the established
principles of prevention policy in Austria (cf. ÖBIG 1999b). These guidelines will be
discussed with prevention experts from various fields on the occasion of a “networking
conference”, which will be held in autumn 2000. Among other provisions the guidelines
stipulate that only specially trained officers shall work in the field of prevention, that their
activities shall be coordinated with other prevention experts and that only approved materials
shall be used for this purpose.
To improve the cooperation between the police force and drug experts (cf. also Chapter 10)
two projects are being implemented in Vienna and Upper Austria, both of which are co-
financed by the Healthy Austria Fund: in Vienna a joint further training programme dealing
with quality assurance of work with drug addicts and in the field of primary prevention was
prepared, addressing drug facilities and the police force, so as to promote mutual understan-
ding of the work of the either group and to improve cooperation. The initial results of the
evaluation indicate that all participants are highly motivated (cf. Drogenkoordination Wien
2000). The Upper Austrian project “PräGend”, in addition to joint further education schemes,
also includes an ongoing exchange of information by means of a newsletter, coordinative
and reflective discussions and concrete on-the-spot cooperation (cf. Institut für Suchtpräven-
tion 2000).
9.6 Specific targets and settings
Regarding demand reduction more and more measures are aimed at specific target groups
or areas. A number of these interventions will be described for illustration.
Gender-specific interventions form an integral part of the Austrian drug help activities, with
special emphasis placed on creating specific services for women (cf. ÖBIG 1999). For
instance, since 1999 the low-threshold facility KOMFÜDRO in the Tyrol, which is open
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exclusively to women at certain hours, has also provided pregnancy tests and homoeopathic
remedies for menstruation discomfort. In Vorarlberg services for women working as
prostitutes for the purpose of drug acquisition have been created in the context of the EU
project “Umbrella”. Investigations of the need for such services confirmed that facilities aimed
at specific target groups and situations in life were necessary and that the programme should
also include activities targeting the customers of prostitutes (cf. also EDDRA). In the context
of its outreach activities Streetwork Vienna contacts both male and female prostitutes
working for the purpose of drug acquisition. The Viennese drug facility DIALOG (cf. also
Chapter 8.2) takes part in a planned EU project aimed at creating services meeting specific
needs of women to help them to leave the cycle of violence and addiction. This project
addresses both women’s shelters and drug facilities.
In the last few years the children of addicts have become an increasingly important target
group of drug-related interventions (cf. ÖBIG 1999a). In the context of the Viennese project
„Pregnancy and Drugs“ the children concerned receive aftercare until the age of six. Now the
first results of a longitudinal survey of a total number of 106 of these children are available
(Elstner et al. 2000). It has been shown that early intervention already during pregnancy,
combined with comprehensive counselling and care, may considerably reduce the specific
problems and risks of these children. Substitution treatment with slow release morphines
helped to reduce neonatal withdrawal syndrome, with buprenorphine administration even to a
considerable extent. Long-term observations showed that the number of children with
clinically significant psychopathological symptoms was surprisingly small, although the
cognitive development of most of the children was affected.
As has already been mentioned (cf. Chapter 8.2) the workplace has become a more
important setting for prevention. In the Tyrol the relevant need was surveyed in 1,000 enter-
prises already in spring 1999. The survey formed the basis for specific measures prepared in
the context of the programme “Prevention in Enterprises”. This programme aims both at
establishing addiction prevention in enterprises and at supporting personnel managers so as
to facilitate early detection and intervention in the case of addiction problems. Both the
Tyrolean prevention centre “kontakt & co” and the Addiction Prevention Unit SUPRO of
Vorarlberg are involved in a European project in the context of which an interactive CD-ROM
for the training of multipliers was prepared. SUPRO also carries out the project “Health Pass-
port” addressing trainees. Among other measures a peer coaching system will be introduced
in this context. The Information Centre on Addiction Prevention of the City of Vienna
coordinates the model project “Addiction Prevention among Trainees of the Austrian Federal
Railways”, which includes drawing up definite guidelines for dealing with drug problems in
the enterprise as well as communicating health-promoting and addiction-preventing aspects
in the enterprise and residence hall for trainees in a process-oriented way that takes into
account concrete needs. Similar activities have also been planned in other provinces.
The results of a survey at a “scene” location in Vienna, which are presented in Chapter 4.1,
show that youths of immigrant families very often have serious social problems. Therefore
the report (AG SCHOP 1999) also points out that confidence-building measures aimed at
specific target groups should be taken, and suggests a combination of outreach work and a
“clearing” place where the need for counselling is assessed and contacts to existing services
are provided. However, so far hardly any specific services have been established in Austria.
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In Salzburg a working group was appointed to deal with the development of specific
(secondary) prevention measures for young persons and juvenile adults from families of
foreign origin.
The number of self-help groups for addicts continues to be small in Austria, and pertinent
initiatives are primarily taken by relatives of addicts. A few drug help projects have adopted
the peer approach, which has been used in the field of primary prevention for a long time al-
ready. For instance, the “Umbrella” project of Vorarlberg (see above) employs women wor-
king in the sex industry for training activities, and Streetwork Vienna also bases its activities
for the prevention of infectious diseases on the multiplier effect of peers (cf. Chapter 13.3).
Alternatives to punishment are a specific field of demand reduction. According to the
Narcotic Substances Act (NSA) reports to the police of a person possessing a small quantity
of narcotic drugs for the purpose of personal use may be temporarily withdrawn (on pro-
bation; Art. 35 of the NSA) or proceedings may be dismissed (Art. 37 of the NSA; cf. Chapter
1.2) if the person concerned is willing to undergo a necessary health-related measure (cf.
also ÖBIG 1999). The district authorities (i.e. public health officers) are responsible for
deciding if a health-related measure is necessary and appropriate. In addition the courts, in
the case of a conviction and if the prison sentence imposed does not exceed three years,
may suspend the sentence so that the offender may undergo a health-related measure (Art.
39 of the NSA). The courts must not specify where this measure shall be carried out, as this
is always up to the person concerned. So in the context of alternatives to punishment addicts
may choose among a broad range of drug help facilities and many different services,
including substitution treatment, psychosocial counselling etc. Schweizer Haus Hadersdorf
(SHH) is a facility specifically created in the framework of “therapy instead of punishment”.
Established in Vienna in 1998 with the explicit purpose of implementing the NSA, it is
primarily aimed at convicted addicts (cf. also EDDRA).
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10 Quality assurance
As has been described in Chapter 8 quality assurance procedures are becoming increasingly
important in the field of drug-related demand reduction, and many concrete measures have
been taken to this end. The guidelines for the announcement of drug facilities under Art. 15
of the NSA (cf. Chapters 8.1 and 9.2) and the guidelines for addiction prevention by police
officers (cf. Chapter 9.5) have already been discussed. In addition similar plans and activities
have been carried out in many provinces. The drug plan of Lower Austria includes guidelines
for quality work and minimum standards for all fields of addiction activities. In Carinthia
guidelines for the case management of substitution clients were drawn up (cf. ÖBIG 1999a).
In the Tyrol minimum standards were defined as quality prerequisites for drug and alcohol
counselling and will be implemented in a stage-by-stage plan. In addition the project
StaffDevelopment is being carried out, which includes all Tyrolean drug facilities. Getting to
know the individual facilities in a structured way as well as their modes of cooperation will
form the basis for improving the network of drug facilities and for reducing competition and
obstructive factors. In Vienna special competence centres were established, which play an
important role in the field of quality assurance. They are responsible for ensuring the transfer
of information and networking also with fields of activity that do not explicitly deal with drug
issues (e.g. youth work, health care etc.) and thus for observing the quality of interventions.
Evaluation also plays an increasingly important role for assuring the quality of projects and
activities (cf. also Chapter 9). It is becoming a standard instrument in the field of drug help,
although the funds earmarked for evaluation are still limited. Therefore many projects and
facilities have to evaluate their own work, as no external evaluation is possible. In Austria,
apart from EU programmes, only the Healthy Austria Fund (HAF) requires evaluation as an
obligatory prerequisite for project support. Funds of the HAF, which supported a number of
evaluations last year, have increasingly been used for evaluation purposes. In addition
evaluation is more and more often carried out in cooperation with universities or affiliated
science centres, so evaluation surveys may be conducted in the context of graduate papers
and theses. The evaluation results are included in the practical work with clients and often
lead to an adaptation of the services offered or the start of new activities (cf. e.g. Chapter
9.4). Evaluation is an important subject in further training programmes for drug experts. In
autumn 1999 ÖBIG organised its first training scheme on project presentation and evaluation
for the target group of drug experts. As it was very successful it will be repeated in the year
2000. Based on the feedback to the training scheme a “quality circle evaluation” was
established for the region of Vienna. In monthly meetings of drug experts dealing with
evaluation both the theory and methods of evaluation as well as practical experience and
problems are discussed. In this context a paper on the general conditions and principles of
evaluation in the field of drugs will also be prepared.
Apart from evaluation surveys a number of other research projects are carried out in the
context of demand reduction. In Part 2 some studies have been presented (cf. Chapters 2.2,
2.3 and 4.1), whose results regarding risk and protection factors or specific social problems
of drug users will be integrated in the practical drug help activities. In addition research has
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also played a more important role already at the planning stage of projects, i.e. for assessing
the actual demand as well as specific needs and requirements (cf. e.g. Chapter 9.6). So far
no drug or addiction-specific research programmes have been drawn up in Austria, so
projects and studies do not follow an overall structure but they often arise from practical work
or reflect the specific research interests of the authors. However, in future drug-related
research could be given a fresh impulse by the establishment of the “Interdisciplinary
Addiction Research Unit” (IARU) at the University of Vienna. The IARU will be responsible for
initiating and coordinating research activities concerning drugs and addiction and will thus
complement the two existing research institutions in the field of addiction (Ludwig Boltzmann
Institute for Addiction Research, Addiction Research Institute of the University of Innsbruck).
Education and training measures constitute another relevant aspect of quality assurance.
Recently the corresponding services have been considerably expanded (cf. also Chapter 9).
In autumn 2001 a new cycle of the three-semester university course “Professional work in
the field of counselling and care of addicted patients” will be started in the Tyrol. In Vienna
the Forum Addiction Prevention Vienna – Workshop for Interdisciplinary Training and Expert
Consulting was founded, which also organises further training courses for drug experts and
experts in other fields dealing with this issue (schools, youth work, health care etc.). The HAF
offers further training programmes on quality management, evaluation and public relations,
among other subjects, for the target group of health promotion experts. There are a large
number of other further training courses, seminars and conferences complementing the
activities and services mentioned, which cannot be described in detail here. One example for
the broad range of activities is the “Moving Conference: Intoxication. A journey to the limits of
consciousness”, held in October 2000. It addresses experts in the fields of youth, drug and
social work and addiction prevention, who will deal with the subjects of “intoxication and
ecstasy” during a train ride.
PART 4
Key issues
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11 Drug strategies in Austria
11.1 National policies and strategies
11.1.1 Principles of national drug policy
At the federal level Austria has not defined a national drug strategy, although the central
objectives and principles of the national drug policy as it is practised provide the foundations
for the relevant laws, and in the last few decades they have also formed the basis for state-
ments and activities both by political representatives working in this field (e.g. press informa-
tion) and by experts responsible for implementation (e.g. Federal Drug Coordination). Unlike
in the fields of the courts and the police the federal competences regarding health care only
cover legislation but not the execution of laws. So in this context the Federal Government is
responsible for providing a uniform framework for the actual design and implementation of
measures at the provincial level. The last time this framework was redefined was in 1998
when the Narcotic Substances Act (NSA) and the pertinent implementing regulations were
adopted.
Accordingly the national drug policy of Austria follows a “comprehensive and balanced
approach” and is based on a few central principles that have been further developed
continually since the early 1970s and are also reflected in the relevant legal provisions. The
Narcotic Drugs Act of 1971 already pointed out that drug dependence was a disease, and
the principle of “therapy instead of punishment” was introduced. Consequently the drug
policy aimed at a strategy that distinguished between drug dependence and drug trafficking.
In this connection drug addiction has been defined as a disease in a psychosocial context.
This points to the principle that help for addicted patients by means of social and health po-
licy measures shall have priority over repressive methods. This principle was also observed
in the legal provisions regulating alternatives to punishment and the model “therapy instead
of punishment” for addicted offenders. The health and social policy interventions are comple-
mented by police and penal measures aimed at drug control, especially the prevention of
illegal drug trafficking.
The main objective of the Austrian drug policy is a society as free of addiction as possible. In
addition to approaches aimed at complete abstinence, in the last few years the importance of
measures of accepting assistance has been emphasised more strongly, with the objective of
limiting drug-related risks and harm. Here the health policy aim is to provide a set of
integrated measures of prevention, treatment, rehabilitation and accepting assistance aimed
at risk-minimisation in a diversified, multiprofessional help network. The increasing diversity
of therapeutic options in the field of drugs in Austria is regarded as an important step towards
the aim of viewing and treating dependence diseases at the same level as other organic and
psychological diseases. Based on the principle that it is better to prevent than to cure and
better to cure than to punish prophylactic measures are given special priority. It cannot be
assessed yet if this drug policy approach will be continued or restructured as a consequence
of the change of government in February 2000. However some measures that have been
planned rather indicate that the Austrian drug policy may become more repressive at least to
some extent. In Chapter 1 these developments have been described in more detail.
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11.1.2 Provincial drug plans
Due to the federalist structure of the field of health and social affairs the provinces play a
major role in planning and implementing drug policy measures, and the majority of the
provinces have drawn up explicit drug plans. At present seven provinces have drug plans:
Lower Austria (Amt der Niederösterreichischen Landesregierung 2000), Carinthia (Amt der
Kärntner Landesregierung 1995), Salzburg (Amt der Salzburger Landesregierung 1999),
Styria (Berthold 2000), the Tyrol (Amt der Tiroler Landesregierung 1993), Vorarlberg (Amt
der Vorarlberger Landesregierung 1991) and Vienna (Drogenkoordination der Stadt Wien
1999). The years of publication show that considerable efforts in this field have been made
especially in recent years (cf. also Chapter 1.1). It should also be mentioned that the drug
plans both of the Tyrol and of Carinthia are being reviewed and brought up to date. Upper
Austria has prepared a number of papers defining the general framework of the drug policy
of the province, and it has been planned to draw up a drug plan. Most of the strategies
adopted in this context were defined in cooperation with a large number of actors in the field
of drugs (from political representatives to experts involved in practical work).
A comparative analysis of the provincial drug plans available so far shows that the basic
principles, aims and kinds of measures are very similar. In some cases different aspects are
stressed or the wording may not be identical, but the basic positions are the same in all
cases. Another common aspect of the provincial drug plans is that, based on the existing
allocation of competences of the Federal and the Provincial Governments, the provincial
plans focus on health care and social policy measures while police and court measures only
play a minor role as they are part of the federal competences.
The provincial drug plans are based on a few common principles, which are found in each
plan and correspond with the principles of Austrian drug policy defined by the responsible
actors in the field of drug policy at the federal level in the last few years (cf. Chapter 11.1.1).
Balanced approach: The drug plans of the provinces underline the conviction that an
effective drug policy requires the balanced use of health policy measures aimed at reducing
the demand for drugs on the one hand and penal measures aimed at reducing the supply of
drugs on the other. To solve the pertinent problems diversified strategies and procedures
have to be adopted so it is of central importance to distinguish between drug use and drug
trafficking.
Decriminalisation of drug users: The drug plans of the provinces agree about the importance
of decriminalising drug users and addicted patients. Although decriminalisation of drug users
to the highest possible degree is demanded the majority of the plans do not demand a legali-
sation of drugs. Only the drug plan of the Tyrol, in addition to stressing decriminailsation,
explicitly indicates that legal access to drugs or substitute drugs would be necessary to
prevent negative social effects of illegal drug acquisition.
Addiction is a disease: Another central principle of the provincial drug plans is that addiction
is defined as a disease, and thus addicts are primarily regarded as patients and not as
offenders. Correspondingly it is emphasised that health policy interventions for drug users
and addicts based on the principle of “help instead of punishment” should be given clear
priority to repressive actions. The provincial drug plans also point out that an integrative drug
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policy is necessary to counteract the marginalisation, discrimination and stigmatisation of
drug addicts.
Comprehensive view of addiction: The drug plans of the provinces are based on a compre-
hensive view of addiction. However, only the “Addiction Plan” of Lower Austria comprises
both legal and illegal substances. The drug plans of the rest of the provinces mention that
addiction to legal drugs is a relevant health policy issue, but – with the exception of the field
of prevention – they focus on illegal substances, which is explained by the need to adopt
diversified, specifically tailored strategies to solve this problem. Still, taking a comprehensive
view means that the entire complex of addiction (physical, mental, psychological, social and
legal aspects) has to be considered, which requires comprehensive, all-embracing measures
especially in the field of social and health policies (cf. also “intervention areas” below).
Principles of drug help: The general drug policy principles described above are complemen-
ted by specific principles for practical drug help activities. The provincial drug plans stress the
aspect of an orientation towards concrete needs as a central requirement for drug help
activities. From these principles further requirements ensue, such as orientation towards
specific target groups, diversity, flexibility and a sensitive approach of counselling services. It
is also pointed out in general that drug help shall be multidisciplinary and provided in a coor-
dinated way. This applies both to the activities of individual facilities and projects and to net-
working structures between the individual services, institutions and areas.
Moreover the provincial drug plans include a hierarchy of goals, which are set in
accordance with their actual practicability. The most important goal is to reduce injury to
health as well as social harm resulting from drug use. First of all this shall be achieved by
preventing persons from beginning to take drugs. However, the aim of a drug-free society is
considered unrealistic in the drug plans. Even regarding the goal of a society as free of drugs
as possible it is admitted that this cannot be achieved in all cases. To meet the aim of re-
ducing injury to health and social harm due to drug use, in addition to preventive and thera-
peutical interventions, accepting drug assistance measures also play an important role (cf.
also “intervention areas” below).
The activities aimed at persons already addicted to drugs follow a similar hierarchy of goals.
The corresponding interventions range from preserving the life of clients and improving their
health and psychosocial situation to abstinence and eventually regaining individual abilities
and competences as well as social reintegration of drug patients.
Another drug policy aim is to de-emotionalise the public and political drug discourse. To this
end intensive, objective public relations work is necessary, which may also contribute to
decrease criminalisation and stigmatisation of drug users and addicts.
All provincial drug plans refer to various intervention areas. The drug plans of Vienna and
Styria define four pillars of drug policy: prevention, health-related measures, social measures
and public safety. Some of the other plans, as a consequence of the competence structure,
do not include safety, and only health and social policy interventions are taken into account.
As a result of the comprehensive approach to addiction and considering the social
complexity of the problem of addiction, all drug plans demand that a drug help system based
on a network of many different, but integrated care services be established. The correspon-
ding intervention areas range from primary prevention and secondary prevention to
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accepting drug assistance, risk minimisation and substitution measures as well as
abstinence-oriented treatment and rehabilitation. According to the hierarchy of needs, i.e.
that priorities have to be derived from the demands and needs of the specific target group,
low-threshold services (cf. Chapter 9.2) are regarded as equal to high-threshold measures.
The drug plans are aimed towards implementation and therefore they include a number of
concrete measures in individual intervention areas depending on the province in question.
The drug plans also stress the central importance of quality assurance. In this context they
point to the prerequisite of qualified education and (further) training, ongoing monitoring, defi-
nition of quality standards, evaluation and research. The drug plan of Vienna also includes
plans to establish competence centres in many areas providing expert knowledge and
serving as interfaces between general and specialised facilities (cf. also Chapter 9.1).
11.2 Application of national strategies and policies
1.2.1 Organisational framework of drug policy
There are fixed organisational structures at the federal level to ensure the coordination of all
drug policy areas (cf. also Figure A1 of Annex B). In July 1997, based on a decision of the
Council of Ministers, the Federal Drug Coordination (FDC) was established. In this context it
was stressed that the drug problem was a cross-cutting issue, for which efficient coordination
both at the national and international levels played a central role. So the FDC is to serve as a
forum and focal point of coordination at the federal level.
The FDC has three members: according to the existing allocation of competences they
represent the Federal Ministry for Social Security and Generations (FMSSG), the Federal
Ministry of the Interior (FMI) and the Federal Ministry of Justice (FMJ). The main responsi-
bility rests with the health department of the FMSSG. To guarantee practical cooperation and
coordination, representatives of other ministries involved in this matter are also included in
specific cases. In addition to coordinative functions the FDC is also responsible for preparing
and consulting ministerial activities, i.e. preparing decisions. Moreover the FDC also assists
in coordinating the representation of Austrian at the international level. Representatives of
Federal Ministries sitting on international agencies and specifically in the EU, have to
coordinate their activities with, and report to, the FDC. The FDC is also responsible for coor-
dinating provincial and federal drug policies so as to ensure a coherent representation of the
Austrian drug policy in international bodies.
The coordination tasks mentioned are performed by the Drug Forum (DF), among other
bodies. The DF is a cooperation forum consisting of the Drug Coordinators or Drug Repre-
sentatives of the Provinces, representatives of the Federal Ministries, the Local Government
Federation and the REITOX Focal Point Austria as well as a few selected scientists. It meets
approximately every three months for the purpose of a general exchange of information and
for discussing specific questions. The DF is an advisory committee of the FDC dealing with
fundamental questions of drug policy. Therefore the meetings serve the purpose of drawing
up basic positions concerning drug issues as well as pertinent recommendations. For
discussing specific subjects the DF may also establish working groups that include external
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experts. The results provided by the working groups are then integrated in the work of the
DF.
However, the central disadvantage of these organisational structures at federal level is lack
of personnel resources to perform the coordinative functions to a sufficient extent. There are
no funds earmarked available either for the Federal Drug Coordination or for the manage-
ment of the Drug Forum.
At the provincial level drug policy functions are taken over by the Drug Coordinators (DCs)
and Drug Representatives nominated for this purpose (cf. also Figure A1 of Annex B). Their
actual competences markedly differ according to province, especially with regard to available
resources and competences. In most cases the DCs are responsible for the planning and
practical implementation of drug policy measures, while the Drug Representatives primarily
perform advisory functions. So implementing the drug plan of the province is one focus of
activities to be performed by the DCs. This function is becoming more and more important,
which is also reflected by the fact that an increasing number of Provinces have appointed
DCs (cf. also Chapter 1.1) and provided clearly defined resources to enable them to perform
their work.
In all provinces there are regional addiction or drug advisory boards comprising
representatives of the most important local institutions in the field of drugs and performing
advisory functions. In addition to drug help facilities the boards often also include representa-
tives of other relevant sectors (e.g. health and social care, schools, young people, the labour
market, the police force) and political parties so as to ensure harmonisation on a broad basis
as well as a comprehensive and integrative approach (cf. Chapter 11.1.2).
Inter-regional coordination of the provincial drug policies is performed by the Provincial
Conference of Drug Coordinators established in 1995. Its members regularly meet to discuss
current drug policy issues and draw up joint positions and statements.
11.2.2 Implementation of drug policy principles
Austria has no defined national drug strategy and no action plan that could be used as a re-
ference document, so obviously it is difficult to assess the actual implementation of drug
policy principles. In this chapter, based on the data and information available, we will never-
theless attempt to provide such an assessment of the practical implementation of the drug
policy principles defined above.
The central principles of the Austrian drug policy are that addiction should primarily be
regarded as a disease and, consequently, that comprehensive, balanced strategies based on
a distinction between drug use and drug trafficking should be adopted. So in the case of drug
use and addiction, health and social policy interventions should definitely be given priority to
repressive measures.
The fact that these principles are actually implemented is shown in the legal framework,
where it is laid down that alternatives to prosecution and the model “therapy instead of
punishment” be made available to drug users and addicted offenders. This trend has become
more pronounced when the Narcotic Substances Act (NSA) was adopted in 1998. Under the
NSA a balanced use of criminal and health policy instruments is also possible in the case of
Drug strategies in Austria
56
minor offences committed in connection with drug acquisition and not only for drug offences
as such (cf. ÖBIG 1999a). The relevant figures show that the legal options provided by the
NSA are also applied in practice: in the last few years the number of convictions for drug
offences have been rather stable: around 3,500 cases annually (cf. Table A15 of Annex B).
In the same period the number of reports to the police that have been withdrawn temporarily
and the number of proceedings dismissed have doubled from approximately 3,500 in 1994 to
more than 7,000 in 1998 and 1999 (cf. also Chapter 4.2).
However, this rise is primarily due to a strong increase of reports to the police, which many
experts regard as contradictory to the drug policy goals defined. The aspect mostly criticised
is not that the total number of reports have been rising in the last few years (1990: 4,829;
1994: 12,623; 1999: 17,211; cf. also Table A12 of Annex B), but rather the fact that this
increase is mostly due to a strong rise in the number of reports to the police concerning drug
use. While reports because of felonies (serious offences, especially drug trafficking) have
remained more or less constant and have even decreased recently, the reports because of
misdemeanours (minor offences, especially drug use) have increased very strongly (cf. also
Chapter 4.2 and Figure 4.1). In 1999 1,956 felonies were reported to the police, but as many
as 15,090 reports concerned misdemeanours. In addition a high percentage of the reports
were made because of cannabis offences (1999: 17,236), while reports in connection with of
opiates (1999: 2,524) have shown a declining trend for the last few years (cf. Table A13 of
Annex B). This problem has repeatedly been discussed by the Drug Forum, which also
criticises the trend concerning police reports, as this is not in line with the drug policy
principle regarding repression, i. that the focus should be placed on fighting drug trafficking
rather than on punishing consumption. The Drug Coordinators of the Provinces also point to
the critical consequences for secondary prevention of such a development: even if
alternatives to punishment are applied, a prior report to the police often involves at least
some extent of criminalisation with undesirable negative effects (e.g. job problems), which is
contradictory to health policy aims (cf. also Hacker 1997). In the context of the present legal
framework this problem cannot easily be solved as the police are obliged prosecute and
report offences under the “principle of legality”. However, the Ministry of the Interior attempts
to promote a stronger focus on fighting drug trafficking and especially organised crime by
means of corresponding instruction courses for the police force (cf. Chapter 9.5).
Among drug experts the model “therapy instead of punishment” – which is another
consequence of the principle that addiction be considered a disease and that health policy
measures be given priority – is generally regarded as an example that the drug policy
principles have been implemented successfully. However, the implementation of this model
is limited by the scarcity of funds. As necessary health-related measures should not be
rendered impossible for lack of funds on the part of the offender the NSA provides that the
Federal Government shall be subsidiarily liable for taking over the relevant cost if no claims
can be made with the legal social security institutions or on the basis of the welfare
assistance laws of the Provinces. But as the provincial welfare assistance laws also include
subsidiarity provisions there is a “negative conflict of competences”. As a result of the rising
number of cases paralleled by stagnating, and recently even declining, funds (cf. Chapter
1.4) the question which authority shall take over the relevant cost (which has not been
defined unequivocally) has led to growing conflicts between the Federal and Provincial
Governments. So many political actors demand that a long-term solution to the question of
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cost coverage be found soon in order to ensure the implementation of the model “therapy
instead of punishment”, in line with the corresponding health policy aims.
Another drug policy issue closely related with the prevalence of health policy measures for
drug users is the need to create a diversified, multiprofessional help network providing a
range of integrated drug help measures from prevention to social reintegration. If one looks
at the development of the drug help system in Austria this aim seems to be implemented
satisfactorily. The drug help sector was considerably expanded regarding both the number of
facilities and the quality of the services rendered, in particular over the past ten years. In
addition a high degree of diversification has been reached as many specific projects oriented
towards concrete needs and demands were initiated. As this expansion was primarily
supported by the individual provinces the extent of this expansion considerably differs accor-
ding to province, but generally speaking this trend applies to the whole of Austria (cf. Chapter
9).
Naturally this development of the drug help sector also leads to markedly higher expenses
(especially on the part of the Provinces) for demand reduction interventions. But still, a
comparison of the estimated expenses (Bruckner/Zederbauer 2000) for the individual areas
shows that the approach of a “balanced drug policy” has not been adequately reflected in the
allocation of funds: while an estimated amount of ATS 1,330.5 million (EUR 96.7 mill.) is
spent for criminal prosecution measures, only ATS 741 million (EUR 41.3 mill.) is used for
measures aimed at demand reduction (cf. Chapter 1.4 and Table A1 of Annex B).
11.2.3 Evaluation
Although the regional drug plans emphasise that evaluation is very important for quality
assurance, none of the plans explicitly includes an evaluation of the implementation of the
drug strategies as such or of the drug policy approach. Still, an evaluation of the drug plan of
the Tyrol, drawn up in 1993,  has been scheduled for the next few months. The results of the
evaluation will serve as the basis for revising the drug plan and bringing it up to date.
There are no scientific studies dealing with an evaluation of the Austrian drug policy, but a
few special areas or aspects were surveyed. Eisenbach-Stangl (2000), analysing the relation
between “prosecution and treatment”, shows that the expansion of drug help services was
speeded up most noticeably in the provinces of the Tyrol, Vorarlberg and Vienna, where in-
tensive police activities (in terms of reports to the police per 100,000 inhabitants) were ob-
served as well. Eisenbach-Stangl concludes that repression and demand reduction cannot
just be regarded as opposites in the Austrian drug policy, but that there is an interrelation and
interaction of the two approaches. For instance, an increase in the number of reports to the
police may call attention to the drug problem, which in turn triggers the expansion of treat-
ment facilities. According to Eisenbach-Stangl in practice the two “supervision systems”
(criminal prosecution and treatment) compete for “their” clients on the one hand, but on the
other new forms of cooperation may emerge as well (cf. Chapter 9.5).
In her legal science thesis Beishammer (1999) dealt with the implementation of the principle
“therapy instead of punishment”, among other aspects. First of all she points out that the
Austrian drug policy includes elements of the “legal approach” (criminal prosecution), of the
“social approach” (therapy instead of punishment) and of the “liberal approach” (withdrawal
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of reports to the police, etc.). Taking this into account the model “therapy instead of punish-
ment” may be regarded as a “forced relationship” between the court system and the drug
therapy sector, which may easily lead to problems especially when it comes to assessing
structures, results and goals of treatment. The potential for conflicts becomes most apparent
in the case of “abstinence” as a direct goal of therapy, as the views of the importance of
abstinence markedly differ. However, this problem became less pressing when the scope of
“health-related measures” defined in the Narcotic Substances Act was expanded to its pre-
sent form, which explicitly includes substitution treatment. So one may conclude that the prin-
ciple of “therapy instead of punishment” has been implemented to a high degree.
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12 Cocaine and base/crack cocaine
Information and data concerning cocaine are very limited in Austria. On the one hand this is
due to the fact that one the one hand the group of persons who exclusively use cocaine tend
to be socially inconspicuous so they cannot easily be covered epidemiologically, and on the
other hand the majority of the available research studies on drugs and addiction have
focused on opiates so far. As a consequence statistical data on cocaine use and the number
of consumers is rare in Austria. The existing information primarily comes from surveys on the
general drug situation (drug scene, youth studies etc.) that do not specifically focus on
cocaine.
12.1 Different patterns and user groups
Cocaine is primarily used as a recreational and party drug. It is taken in particular in the
leisure time and during the weekend, and usually it is snorted. A rather new development of
the last few years is that cocaine has entered the drug street scene, at least in Vienna. Here
it is also used intravenously to some degree, often combined with heroin (“speedballs”).
Injecting cocaine mixed with heroin is becoming an increasingly popular pattern of use.
According to estimates for Vienna approx. 300 to 400 persons use speedballs (Strobel und
Silbermayr 1999).
As is shown by a number of representative studies (cf. Chapter 2.2 and Table A3 of Annex
B) a maximum of one to two percent of the population indicate experience of cocaine. These
figures are confirmed by estimates based on the practical experience of drug help facilities,
where a lifetime prevalence between 0.3 and 2.2 percent among the adult group of the
population is assumed. In addition it is estimated that there are between approximately
10,000 and 15,000 problematic cocaine users in Austria, and that their number is on the rise
rather than declining (Strobel und Silbermayr 1999).
In Austria three relevant groups of cocaine problem users may be distinguished. The first
group consists of young drug users experimenting with many different substances. The
second group comprises persons consuming no other illegal substance than cocaine. The
third group includes persons of the drug scene who use cocaine among other drugs in the
context of polydrug use.
Data about the first group is found in a number of youth studies. As has been mentioned
above, in the context of representative surveys only between one and two percent of the
youths reported experience of cocaine, although these figures are markedly higher among
specific youth subcultures, especially in the rave scene, which is characterised by a high
affinity to drugs. For instance, when the guests at raves were interviewed about their drug
experience in the context of the Viennese project ChEck iT!, 30 percent indicated that they
had already used cocaine. On the other hand the figures for very many other substances
were also high (e.g. 53% for ecstasy, 60% for speed and 30% for smart drugs – legal psy-
choactive substances obtained from plants). The drugs – including cocaine – are preferably
taken among friends at raves and in clubs. In addition polydrug use is very common,
although  the  majority  of  the  respondents  indicate  that they  never  combine  ecstasy  and
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cocaine, and ecstasy and speed only in rare cases. These substances are most often
consumed among a group of friends, and in the case of cocaine 64% indicate this pattern of
use. The substances are bought from friends or dealers known to the users (Kriener et al.
1999).
In the context of the EU project “Drug affinity of young persons in the techno party scenes of
European cities” (Tossmann et al. 1999) Austrian techno events were also investigated, both
in Vienna and in Vorarlberg, in order to obtain complementing data for more rural areas. The
results for Vienna are similar to and comparable with those of ChEck iT! in many respects,
while a markedly lower percentage of the persons interviewed in Vorarlberg indicated
experience of illegal drugs (cannabis: 59%, ecstasy: 32%, speed: 26%, hallucinants: 23%,
cocaine: 16%). This group also indicated a smaller degree of polydrug use and showed more
caution concerning simultaneous use of different substances.
A recent, although not representative, study entitled “The importance and consumption of
psychoactive substances among Austrian youths” (cf. Chapter 2.2) also provides information
on the experience of cocaine among specific youth scenes. The drug use indicated by the
four groups studied (ravers, youths practicing fun sports, young association members,
control group) shows that the tendency towards experimenting with illegal drugs is strongest
among ravers (cannabis: 82%, ecstasy: 64%, cocaine: 42%), followed by the fun sports
group (cannabis: 76%, ecstasy: 10%, cocaine: 22%). The other two groups show a smaller
tendency towards illegal drug use. However, the figures concerning illegal substances are
considerably lower in all groups if drug use in the past three months is considered: cocaine is
indicated by only 12 percent of the ravers, four percent of the fun sports group and the other
two groups do not indicate any cocaine use (Springer et al. 1999).
However, one should bear in mind that these studies are investigations of a very specific
youth subculture characterised by a high affinity to drugs and that the results do not claim to
be representative by any means. As has been mentioned above experience of illegal drugs is
by far less frequent among the total population of young people.
The second group, as mentioned, comprises persons using cocaine as the only illegal
substance. This scene is the least conspicuous one, so there is hardly any information
available. According to Uhl and Springer (1997) this group may be described as the “upper
cocaine scene” mostly comprising closed circles in private and semi-private areas. The
members of the upper cocaine scene are socially well-integrated, they have discreet, reliable
sources supplying them with drugs of good quality, and they avoid contact to the open drug
scene (Uhl und Springer 1997).
Regarding the third group – persons of the drug scene taking cocaine in the context of
polydrug use – data is provided by a number of interview surveys of drug addicts or among
the street scene. A few years ago the Ludwig Boltzmann Institute for Addiction Research
carried out an interview survey of the street scene of Vienna (Uhl und Springer 1997), at the
first stage of which 52 “experts” (counsellors, (former) opiate addicts, police officers) were
interviewed, and at the second stage, 150 drug users of the street scene. The majority of the
respondents showed strong polydrug consumption patterns, i.e. they used many different
psychotropic substances (opiates, cocaine, cannabis, hypnotics, tranquillisers, ampheta-
mines,  designer  drugs, alcohol).  Regarding  different stages  of the drug career  the  survey
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showed that cocaine was important for 10% of the respondents at the early stage, while 52%
indicated that it played a central role during their entire drug careers. 29% had used cocaine
in the past six weeks, compared to 53% using heroin during this period. According to this stu-
dy cocaine still played a minor role in the drug scene of a few years ago. It was regarded as
an expensive drug of the “chic set”. It was only in the past few years that cocaine has be-
come more relevant for the drug scene, where it is mainly used for the following three effects:
· as a substitute for heroin because of the immediate effect (“flash”) after injection
· combined with heroin to increase the drug effect (“speedballs”)
· as a high-level substitute for amphetamines which were legal in the past
The different drug effects “flash” and “activation” lead to conflicts for persons who are
interested only in one component of the combined effect. Most of the persons who do not
want to feel the stimulation caused by cocaine but seek its euphoric effect (flash) tend to
change over to heroin use. Although the prices for cocaine have dramatically fallen in the last
few years it is still more expensive than heroin because of its shorter period of action (cf. also
Chapter 12.3).
Other studies also confirm the fact that cocaine is part of polytoxicomaniac patterns of use.
For instance, in a study carried out by CONTACT, the Vienna hospital connection service (cf.
also Chapter 2.3) 22 percent of 90 respondents indicated that cocaine was a main drug for
them, although more than half of them indicated several substances, with opiates as the
drugs mentioned most frequently (Seidler 2000). Regarding use of “hard drugs” in the past
24 hours 24 percent indicated cocaine, which had been administered intravenously by 61
percent, and 50 percent injected cocaine combined with heroin (“speedballs”).
As shown in a survey among opiate users carried out in 1996 in the low-threshold facility
Ganslwirt in Vienna as well as among the street scene, all of the total number of 59 persons
interviewed consumed several different drugs. 15 percent indicated daily use of cocaine
(44%: heroin, 31%: methadone, 20%: cannabis). Only about one third of the respondents
said that they never used cocaine (Seidler 1997).
In addition to cocaine, crack cocaine is also found many provinces. Although it is a
processed form of cocaine, crack has to be regarded as a separate drug because of its
characteristic chemical composition and kind of action, with addiction and other serious
health problems usually resulting more quickly. Use of crack has never been found among
larger groups in Austria, and obviously the number of crack users have remained small.
In order to obtain additional information on cocaine use in Austria the data available at the
FMSSG, which concerns registration of known drug consumers, was also considered. Based
on this data it was attempted to compare persons registered solely for use of cocaine and
persons registered because of opiate use. From 1996 to 1999 the number of first registra-
tions of cocaine users was between approx. 650 and approx. 1,200 cases, while between
approx. 850 and approx. 1,750 opiate users were registered for the first time. There are no
relevant differences between opiate and cocaine users regarding the majority of the factors
recorded (age, gender etc.) with the exception of the factor occupation: more than 60 percent
of the persons registered because of opiate use were out of work, which is considerably
higher than the relevant percentage for consumers of cocaine: 35%.
Cocaine and base/crack cocaine
62
12.2 Problems and needs for services
According to Uhl and Springer (1997) problems first of all arise from the specific actions of
the substances used. Persons who take stimulants or cocaine on a regular basis often need
hypnotics/tranquillisers, opiates or alcohol in order to calm down again. On the other hand,
many persons who primarily seek the effects of opiates or hypnotics/tranquillisers at first
need stimulants later in order to be able to perform the necessary everyday activities. In
either case antagonistic drug effects are compensated, which leads to a rapidly escalating
cycle of chemical activation and deactivation, which is hard to break after a short time.
Polydrug use, which prevails in Austria, involves serious health and social problems, which
are not specifically related to cocaine although they are very grave if speedballs (see above)
are consumed, in which heroin and cocaine are combined. Another aspect is that the quality
of “street cocaine” is very poor, which entails additional health risks (Strobel und Silbermayr
1999).
There are only few cases among the drug-related fatalities (cf. Chapter 3.2) that have been
caused by intoxications in which cocaine (combined with other substances) but no opiates
were present. The relevant figures are between two out of 174 deaths in 1999 and five out of
226 deaths in 1993, although one may assume that cocaine is also involved in polydrug use
combined with opiates.
With regard to the need for treatment caused by cocaine use there is no data concerning
persons who only take this substance. However, it has been observed that this group of
persons does not tend to turn to drug help facilities (cf. Chapter 12.4). According to what little
information is available from practical work cocaine consumers do not usually consult
outpatient treatment facilities over a lengthy period (Strobel und Silbermayr 1999).
12.3 Market
Data on the cocaine market mostly refers to reports to the police and to seizures of cocaine.
In the past five years the number of reports to the police has risen from approximately 1,600
(1995) to approximately 2,600 (1999), but this upward trend has become weaker recently (cf.
Table A13 of Annex B). In the last three years the number of cocaine seizures have slightly
declined and the quantities of cocaine seized have also decreased (cf. Tables A18 and A19
of Annex B).
Apart from these figures no further indicators for sources of supply and patterns of drug
trafficking have been collected or published routinely, so the corresponding development can
only be estimated, based on experience gathered in the context of the Federal Ministry of the
Interior (FMI). According to these sources illegal imports to Austria of cocaine primarily come
by air, organised by South American dealer groups. Arrested drug couriers indicated that part
of the cocaine was sold in Austria, but most of it was designated for shipment to Italy or
Germany (BMI 2000).
In the street scene cocaine is usually sold in the form of sealed balls, so the customers
cannot check the quality of the cocaine they buy. Another difference between sales of
cocaine and heroin is that it is common practice to bargain for a price with a cocaine dealer,
while heroin is sold for a fixed price.
Cocaine and base/crack cocaine
63
In 1997 the prices for one gramme of cocaine of good quality still were between ATS 1,400
(EUR 102) and ATS 1,800 (EUR 131) (David 1997). Currently the prices for one gramme
range from ATS 1,000 (EUR 73) to ATS 1,200 (EUR  87). Regarding highly diluted (impure)
cocaine sold in the street, where the actual quantity of the original substance can hardly be
assessed, a big ball (rather less than one gramme) costs approx. ATS 500 (EUR 36), and a
small ball (rather less than 0.5 grammes) approx. ATS 300 (EUR 22). Heavy users need
daily doses between two and three grammes (Strobel und Silbermayr 1999).
12.4 Intervention projects
The majority of the Austrian drug help facilities are open to persons with any kind of drug
problem, and thus to cocaine users as well. However, practical experience shows that the
relevant services are hardly used by clients who consume only cocaine, but the treatment
facilities do have clients taking cocaine in the context of polydrug use patterns. For instance,
the 1998 report of activities of Grüner Kreis indicates that 40 percent of the clients admitted
for inpatient treatment had regularly used cocaine before therapy, while the share of regular
heroin users was 57 percent.
To our knowledge there are no drug help facilities or programmes focusing on exclusive
cocaine users, either in the fields of prevention or crisis intervention or treatment, and very
few counselling and treatment facilities have dealt with the physical and psychological effects
typical of cocaine in order to be able to meet the special demands of this group of drug
users. Therefore cocaine consumers are often confronted with the institutional and personnel
limits of the staff of drug facilities. As a rule cocaine addicts are given the necessary space,
time and kind of counselling only in rare instances. The needs of cocaine problem users can
hardly be met in the context of the services provided by the specialised drug facilities
(Strobel und Silbermayr 1999).
On the other hand it is difficult to assess the actual demand for special programmes aimed at
cocaine users. One may assume that most persons of the “upper cocaine scene” would not
turn to “traditional” drug help facilities in case of problems but rather call upon general
medical or psychosocial services and also private treatment. Still, the way of action and the
addiction potential of cocaine are a special challenge for the drug help system. During the
“cocaine stage” cocaine addicts or opiate/cocaine addicts tend to be always “on the move”
and can thus hardly be reached by the existing counselling and treatment services. So in the
opinion of many experts the question of how to deal with cocaine addicts should be a central
issue of the future (Neubauer und Strobel 1998).
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13 Infectious diseases
Persons using drugs (intravenously) run an elevated risk of being infected with a number of
typical diseases. Therefore the European Monitoring Centre for Drugs and Drug Addiction
(EMCDDA) introduced the epidemiological key indicator “Infectious Diseases in Injecting
Drug Users”, and since the beginning of 2000 strong efforts have been made both at the
European and at the Austrian level to implement this indicator. Its main goal is to register
prevalence on the one hand and changes of incidence on the other. The focus of activities
has been placed on the three infectious diseases HIV, hepatitis B (HBV) and hepatitis C
(HCV). It is also considered to include additional infectious diseases such as tuberculosis
(TB) in the key indicator. In spring 2000 ÖBIG initiated a working group at the Austrian level
comprising experts in the fields of epidemiology of infectious diseases, treatment of drug
addicts, low-threshold counselling in the court system, sexually transmitted diseases and
drug policy, where the cooperation for implementing the key indicator at the national and EU
levels is coordinated.
13.1 Prevalence and incidence of HCV, HBV and HIV
among drug users
At present statements concerning the prevalence of HCV and HBV in Austria can only be
based on a number of small samples from the fields of treatment and low-threshold services.
In the case of HIV additional prevalence data of the drug fatalities statistics and of the AIDS
monitoring system are also available. The incidence of HCV, HBV and HIV cannot be
estimated at the moment. In future it is planned to gather data on HCV, HBV and HIV in the
context of the unified client documentation system.
Since the mid 1990s the infection rates of hepatitis C have been registered on the basis of
small samples (individual treatment facilities or low-threshold counselling centres). The data
gathered generally shows high HCV prevalence rates of more than 70 percent in most cases
(e.g. David 2000, ÖBIG 1998, 1999a).
The picture obtained from available recent data confirms this fact and still shows a very high
HCV prevalence. The short-term therapy department of the Anton Proksch Institute in Vienna
reported that 72 percent out of the total number of 68 IV drug patients treated in 1999 had an
HCV infection. The short-term therapy department Lukasfeld in Vorarlberg registered 58
HCV+ cases out of 173 IV drug patients from 1995 to August 2000, while only 35 percent out
of the total number of 34 injecting drug patients treated in the Tyrolean short-term therapy
department Maurach between July 1999 and July 2000 were infected with HCV. All
institutions routinely test their patients for HCV. From April 1996 to March 1999 the hepatitis
serology tests of 117 patients carried out in Pavilion 1 of the Hospital of Psychiatry
Baumgartner Höhe, Vienna, were analysed, which showed a HCV prevalence rate of 85
percent. The low-threshold facilities also report high prevalence rates. Among the total
number of 92 persons (mostly injecting drug users) tested in 1999 in the context of the HCV
testing service of the outpatient clinic at the low-threshold Viennese facility Ganslwirt 63
percent had HCV infections.
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Unfortunately the available data does not cover changes of the prevalence rates over time,
and the actual reasons why the prevalence rates differ so strongly can only be guessed as
well. This may be due to regional differences, but differences in the target groups receiving
treatment or counselling are as likely a reason. In June 1998 the data of the low-threshold
facility H.I.O.B., Vorarlberg (HCV prevalence: 77% out of 94 persons tested) was compared
with the data of the short-term therapy department Lukasfeld (HCV prevalence: 60% out of
110 IV drug users). The higher prevalence found in the H.I.O.B. facility might be explained by
the fact that the clients had used drugs for a longer period already, i.e. for an average of five
years, compared to only 3.2 years in the Lukasfeld department. The staff of the short-term
therapy department of Maurach also attribute the lower prevalence rate to the younger age of
their clients.
When the prevalence rates were analysed according to age and gender, which was possible
only for the Ganslwirt facility and the short-term therapy department Lukasfeld as no further
data was available, inconsistent results showed (see Tables 13.1 and 13.2).
Table 13.1: Hepatitis C prevalence results of the testing service of the low-threshold facility Ganslwirt
according to age and gender from October 1998 to July 2000
< 25 years 25 –34 years > 34 years TOTAL
Male 70%  (40) 79%  (28) 67%  (21)* 72%  (89)
Female 46%  (48) 61%  (18) 75%  (4) 51%  (70)
TOTAL 57%  (88) 72%  (46) 68%  (25) 63%  (159)
The figures in brackets give the total number of persons tested, to which the percentages refer.
* Two patients among the group of men over 34 are included in the HCV+ statistics because of borderline diagnoses.
Source: H. Haltmayer, personal information, calculation by ÖBIG
Table 13.2: Hepatitis C prevalence among IV drug patients of the short-term therapy department
Lukasfeld from January 1995 to August 2000
< 25 years 25–34 years > 34 years TOTAL
Male 36%  (39) 61% (69) 64%  (14) 53%  (122)
Female 59%  (32) 82%  (17) 100%  (2) 69%   (51)
TOTAL 46%  (71) 65%  (86) 69%  (16) 58%  (173)
The figures in brackets give the total number of IV drug patients  treated.
Source: V. Duspara, personal information, calculation by ÖBIG
It can only be speculated why the prevalence rates show considerable differences as to
gender and age. In any case this is a sign that the prevalence rates of IDUs are not uniform
by any means. It is essential to carry out additional research and to improve the data base
for assessing the situation regarding HCV infections as well as risk and protection factors. In
this connection it should also be mentioned that the EMCDDA  has planned a research
project with the provisional title “The prevalence and incidence of hepatitis C virus infection
(HCV) and associated risk behaviours among recent-onset (post 1994) drug injectors in the
EU” and that Austria intends to participate in the project.
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Since the mid 1990s the infection rates regarding hepatitis B are registered as well, but as
in the case of HCV the data is based on small samples. Generally speaking the HBV
prevalence is high, with rates of more than 35% in most cases (e.g. David 2000, ÖBIG 1998,
1999a).
The recent prevalence rates reported by the treatment sector also range from 12 percent out
of 34 IDU patients treated (short-term therapy department of Maurach, the Tyrol) and 64
percent out of 68 injecting drug users treated (short-term therapy department of the Anton
Proksch Institute in Vienna). The short-term therapy department of Lukasfeld, Vorarlberg,
registered a prevalence rate of 29 percent out of a total number of 157 intravenous drug
patients tested for HBV in the period from 1995 to August 2000. An analysis of the hepatitis
serology tests carried out at Pavilion 1 of the Hospital of Psychiatry Baumgartner Höhe,
Vienna, between April 1996 and March 1999 resulted in a HBV prevalence rate of 35 percent
(out of a total number of 117 patients).
The figures concerning the low-threshold sector were provided by the outpatient clinic of
Ganslwirt: 48 percent out of a total number of 307 persons tested in 1999 in the context of
the hepatitis B vaccination project had HBV infections.
Unfortunately possible changes of the hepatitis B prevalence rates cannot be assessed
either. In addition no reason can be given why the prevalence rates reported by the individual
institutions noticeably differ from each other. As one might expect, the facilities where the
HCV prevalence rates are rather low also report lower HBV infection rates. As in the case of
HCV prevalence the differences could be due to regional differences or different target
groups.
As is shown by an analysis of prevalence rates according to age and gender, which could be
made for the short-term therapy department Lukasfeld only because no other data was avail-
able, the HBV prevalence rates tend to rise with the age of the patients (see Table 13.3).
Table 13.3: Hepatitis B prevalence among IV drug patients of the short-term therapy department
Lukasfeld from January 1996 to August 2000
< 25 years 25 - 34 years > 34 years TOTAL
Male 19%  (37) 33% (64) 50%  (10) 30%  (111)
Female 28%  (29) 27% (15) 50%   (2) 28%  (46)
TOTAL 23% (66) 32% (79) 50%  (12) 28%  (130)
The figures in brackets give the total number of IV drug patients  treated who tested positive for HBV.
Source: V. Duspara, personal information, calculation by ÖBIG
However, results of the hepatitis B vaccination project organised by Ganslwirt do not confirm
this: no significant relation between age or duration of IV drug use and the risk of HBV infec-
tion was found (Zach et al. 1999, cf. also Chapter 13.2).
Regarding HIV the prevalence rate among Austrian IDUs was between 10 and 20 percent at
the beginning of the 1990s, but afterwards it declined sharply, and by the end of the 1990s it
was not higher than five percent in any of the sources of data.
In 1999 22 out of a total number of 90 new AIDS patients indicated that they had been infec-
ted by intravenous drug use. While new cases of the disease in connection with injecting
drug use as the source of infection continually rose until 1993 (1987: 28 cases, 1990: 45
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cases, 1993: 59 cases), the figures for 1997 (21 cases) show a strong decline, and now they
seem to be stabilised at a level between 20 and 30 cases (1998: 24 cases, 1999: 22 cases).
This decline is also reflected in the total number of new outbreaks of AIDS. With the
exception of 1995 and 1996, more than 20 percent of the patients with new AIDS outbreaks
had been infected because of intravenous drug use (1999: 24 %). This shows that the risk to
develop AIDS is still considerably higher for IDUs than for the rest of the population (cf. Table
A10 of Annex B).
Data on HIV prevalence is also found in the drug fatalities statistics, but these figures only
cover lethal overdoses of opiates or combinations with opiates. The corresponding
prevalence rate was between one and five percent in the last few years, with an average rate
of 3.2 percent from 1991 to 1999. If the cases of the last three years are analysed as to
gender, it shows that eight out of the total of nine HIV+ cases were male (drug fatalities
statistics of the FMSSG). On interpreting these figures one has to take into account however
that the total number of cases is very low. In addition the prevalence rate of HIV based on
lethal opiate overdoses may be taken as an indicator of the HIV prevalence among the total
group of intravenous drug users to a very limited extent only, as one may assume that
persons with a pronounced “risk behaviour” and/or possibly also persons with very strong
addictions are overrepresented among the overdose cases.
The Tyrolean short-term therapy department Maurach and the long-term therapy department
of the Anton Proksch Institute of Vienna also provided recent data on HIV infections
diagnosed in treatment facilities in 1999. In the same year no case of HIV infection was
registered in either institution. The short-term therapy department Lukasfeld, Vorarlberg, did
not register any HIV+ patients infected because of injecting drug use in 1999 either.
In 1999 three percent out of a total number of 96 persons tested in the context of the HIV
testing service of the outpatient clinic of the low-threshold facility Ganslwirt had HIV in-
fections. The percentage of HIV+ results has been between 1.4 and 5.5 percent since 1992,
but as no routine screening is carried out, these figures may probably be biased. In 1999, as
in previous years, the low-threshold facility H.I.O.B. in Vorarlberg did not report any HIV+
patients (cf. also EDDRA).
On the whole the existing data indicates a stable HIV prevalence rate at a low level, while the
hepatitis prevalence rates are still very high.
13.2 Determinants and consequences
Regarding determinants and consequences only few recent figures about risk behaviour and
risk minimisation are available so far. However, relevant information is provided by a study
on risk factors regarding hepatitis B infections carried out in the context of the hepatitis B
vaccination project of the low-threshold facility Ganslwirt, where detailed data on a total
number of 307 persons was gathered between November 1995 and May 1999. The results
indicate that there is no significant relation between infection with hepatitis B and the
parameters age, duration of drug use and prostitution. According to the authors the absence
of age effects results from the fact that injecting drug users get infected with hepatitis B at an
early stage already so that age or duration of drug use are no additional risk factors. As far
as prostitution is concerned, they assume that the risk of having already been infected
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because of IV drug use overlays the risk involved in prostitution. The indications about risk
behaviour (unsafe sex, sharing of injection equipment) led to the rather inconsistent result
that the prevalence of hepatitis B was lower among the group of persons indicating risk
behaviour than among the risk-avoiding group (the prevalence of hepatitis B for persons
sharing injecting equipment was 47%, but it was 64% among the group indicating never to
share equipment). The authors give the explanation that a number of respondents might
have answered untruthfully because they “feel guilty” or they might have forgotten instances
of risk behaviour in the past (the age group over 30 was significantly overrepresented among
the persons indicating no risk behaviour). Prison experience turned out to be another
significant risk factor. The prevalence rate of hepatitis B was 41% among the group of 130
persons who had never been imprisoned, but as many as 63% out of the total number of 137
persons with prison experience had HBV infections. The possible reasons for the higher
prevalence rate of hepatitis B among persons with prison experience could be that injecting
equipment is rather often shared in prisons (Zach et al. 1999).
In order to study these results in more detail the Vienna Social Projects Associations carried
out the survey “Imprisonment and intravenous drug use”, for which 160 clients of five
Viennese drug facilities who had been imprisoned at least once were interviewed between
May and September 1998. 63 percent out of a total of 83 persons indicating that they had in-
jected drugs during imprisonment had shared injecting equipment with other inmates. The
prevalence rate of hepatitis was higher for persons indicating “sharing in prison” (HBV 62 %,
HCV 79 %) than for persons indicating “no sharing” (HBV 48 %, HCV 69 %) (Neubauer 1999,
cf. also ÖBIG 1999a).
According to a survey covering all Austrian prisons the hepatitis B prevalence rate was five
percent, and the HCV infection rate was 20% among persons taken to prison in 1999 (results
based on figures from all prisons, with a test frequency of more than 70%). One has to bear
in mind however that these figures refer to all inmates, as intravenous drug users cannot be
singled out for reasons of data protection (PONT 2000).
There is no doubt that intravenous drug use by several persons who share injecting
equipment is the most important risk factor regarding HCV and HBV infections. This is
confirmed by the results mentioned above as well as, for instance, by data provided by the
short-term therapy department Lukasfeld, where only very few persons who indicated not to
inject drugs had hepatitis B or C infections. Therefore strategies of risk minimisation should
first of all aim at factors that increase the probability of needle-sharing. Measures to this end
(exchanging/selling of syringes) are well-accepted among the persons concerned, which is
shown by the fact that such services are used more and more often (see next chapter). As it
is generally estimated that between 10 and 20 percent of the Austrian prisoners inject drugs,
drug experts attach special importance to measures preventing infections in this area.
Generally speaking, one may safely assume that the awareness of infection risks has grown
among the Austrian intravenous drug users, not least because of relevant focuses of a
number of drug facilities (Neubauer 1999). This is also confirmed by the low HIV prevalence
rate. However, the need for information, and lack of basic knowledge, about safe use (e.g.
high-risk behaviour such as injections in the inguinal region) and safe sex  continues to be
strong, which becomes apparent especially in the practical work of Streetwork at Karlsplatz,
Vienna (Verein Wiener Sozialprojekte 2000b).
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13.3 New developments and uptake of prevention/harm
reduction, care
Since the late 1980s preventing and treating infectious diseases – in particular HIV and other
sexually transmitted diseases (STDs) as well as hepatitis – has been a central focus of
health policy interventions and especially harm-reducing measures (cf. Chapter 9.2)
addressing drug addicts. In the first few years, because of the current AIDS problem special
importance was attached to the prevention of HIV infections among drug users. As a
consequence syringe exchange programmes were started, syringe vending machines were
provided, and AIDS information campaigns were implemented, paralleled by a distribution of
free condoms, testing for HIV infections of at-risk groups and the provision of substitution
treatment. As of the mid 1990s the focus has been shifted to hepatitis, because the HIV pre-
valence rate declined while the hepatitis prevalence rate was very high (cf. Chapter 13.1).
The corresponding activities were then complemented by specific testing and vaccination
services, among other measures.
As intravenous use is very common among Austrian drug addicts (cf. Chapter 2.3), providing
syringes is an important measure to prevent infections. Syringes are sold by each of more
than 1,000 pharmacies located all over the country, for a price between three and four
Austrian schillings (2-ml one-way syringe including needle, EUR 0.25). In addition a number
of specific services are provided. Syringe exchange programmes and/or syringe vending
machines are found in almost every province, mostly in the capitals, and these services are
called upon by a large group of drug addicts. The development of the syringe exchange pro-
grammes, which are usually run in the low-threshold sector (cf. Chapter 9.2), shows that the
number of syringes exchanged are constantly rising while syringe sales are declining. In
1999 almost 700,000 syringes were exchanged in the open drug scene of Vienna and 85,000
syringes were sold (cf. Figure A3 of Annex B). The drug facility H.I.O.B. in the province of
Vorarlberg also registered a continual increase of the number of syringes exchanged, from
less than 30,000 (1995) to almost 80,000 (1999), with the number of syringes sold remaining
more or less the same (1999: approx. 2,800) (cf. also EDDRA). The Tyrolean facility
KOMFÜDRO reported a high 90% return rate of the total of approximately 43,000 sets
(consisting of a syringe, needle, ascorbic acid, alcohol swab and dry swab) handed out in
1999. In the Tyrol the temporary sleeping facility Mentl-Villa handed out an additional number
of 3,210 syringes in 1999, and 12,352 safe sets were sold in the syringe vending machines
of the AIDS Assistance Service of the Tyrol, for a price of ATS 10 each (EUR 0.70). In the
province of Salzburg two towns have syringe vending machines, with monthly sales between
approximately 150 and 250 packs, depending on the season. Similar services are provided in
other Austrian towns and cities as well (e.g. Linz and Klagenfurt), and they are further
expanded: for instance, the planned Upper Austrian contact point (cf. Chapter 9.2) will also
run a syringe exchange system, and Vienna considers to establish a syringe exchange pro-
gramme for the outskirts of the city. The planned low-threshold project NIKA in the Tyrol (cf.
ÖBIG 1999 and Chapter 9.2) would be the first facility in Austria to include a “health room” for
intravenous drug use. However, the political decision whether to implement this has not yet
been taken.
The prevention measures also include information on safe use and safe sex, handing out
condoms, testing and vaccination services as well as substitution treatment. Activities in this
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field are found both in the low-threshold sector and in treatment facilities. Information and
testing services are also rendered in particular by the regional offices of the AIDS Assistance
Service, among other organisations. By now providing information on infection prophylaxis
has been included in the standard services of the drug help facilities. In Vienna and the Tyrol
special hepatitis folders for drug addicts were prepared, which are also used in other pro-
vinces. In addition a pilot project based on a peer support approach was started in the open
drug scene of Vienna in spring 2000, as practical experience had shown that in spite of the
large number of prevention measures taken so far many patients still had insufficient basic
knowledge and that false information prevailed in the scene. Therefore open information
events were organised on the spot, where safe use and safe sex messages were communi-
cated among the scene, following a low-threshold approach and aiming at the multiplier
effect (cf. also Chapter 9.6) of imparting knowledge in the scene (cf. Verein Wiener Sozial-
projekte 2000b). After the pilot stage the project will be continued and accompanied by an
evaluation.
Anonymous, cost-free HIV tests have been offered in all provinces of Austria for quite some
time already. Parallel to this, hepatitis testing and vaccination services have been
substantially expanded in recent years. Many treatment facilities routinely test their clients for
HIV and hepatitis, and hepatitis tests are often carried out in the context of substitution treat-
ment as well. For instance, since summer 2000 all substitution clients of Styria have received
cost-free testing for hepatitis at the outpatient liver clinic of the University of Graz. In Upper
Austria the patients admitted to substitution treatment are also tested for HIV and hepatitis. In
addition more and more facilities provide cost-free vaccinations against hepatitis A and B.
Vorarlberg was the first province to start a large-scale hepatitis vaccination programme for
drug patients. As addicts cannot easily be reached the programme is not run in medical
practices but carried out in cooperation with first-contact drug centres, counselling and treat-
ment facilities and the prison of Feldkirch so as to increase acceptance of the programme
and to facilitate systematic vaccination. In 1999 324 drug addicts were examined in the
context of this programme, and 174 were vaccinated. The hepatitis B vaccination project of
the low-threshold facility Ganslwirt in Vienna is described in a detailed report (Zach et al.
1999); in 1999 a total number of 93 patients were vaccinated in the context of this pro-
gramme. However hepatitis vaccination programmes are not run on a nation-wide scale so
far due to lack of funding (see below).
Measures aimed at preventing infection are also taken in prisons. In the prison of Favoriten,
Vienna, a central office for the distribution of information material on HIV and hepatitis C was
established. At the beginning of imprisonment every prisoner is given a so-called care pack
consisting of information folders on HIV/AIDS and hepatitis C, condoms and a leaflet indi-
cating specific risks during imprisonment. In addition many prisons cooperate with local
institutions (drug help facilities, the AIDS Assistance Service etc.) to organise information
events on infection prophylaxis. Condoms are available in all, and disinfectants in almost all,
prisons. Between March 1999 and February 2000 a total of 14 percent (2,441) of all newly
imprisoned persons were tested for HIV and 13 percent (2,265) were tested for hepatitis B
and C (cf. Pont 2000). As the infection risk is particularly high during imprisonment (cf.
Chapter 13.2), in 1999 an outline for  a scientific  project examining  the preventive  effects of
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syringe exchange services in prisons was drawn up, but the project has not yet been
implemented.
Treatment and counselling with regard to HIV/AIDS and hepatitis of drug addicts are usually
provided by specialised services (AIDS Assistance Services, outpatient and inpatient de-
partments of hospitals). In 1998 a project dealing with interferon treatment of clients suffering
from chronic hepatitis C was carried out at the low-threshold facility Ganslwirt in Vienna,
however it has turned out that such a service is not practicable in a low-threshold setting
(Verein Wiener Sozialprojekte 2000a).
Because of the high prevalence rates the problem of hepatitis among drug users was also
discussed in a number of working groups in the last few years. In the course of the
meetings of the Vienna Drug Commission in September 1998 the working group “Hepatitis
and drug use” was established to draw up recommendations for health policy measures.
What is primarily demanded in this context is more information and training schemes both for
the clients and the staff of drug facilities, an expansion of the syringe exchange programmes
and substitution treatment, nation-wide testing and vaccination of the high-risk group of IV
drug users as well as extended expert diagnosing and treatment whenever necessary. In
addition the general health care system should be involved more intensively for the purpose
of early detection and treatment so that former addicts may also be included (David 2000). At
the end of 1999, initiated by the Vienna Social Projects Association, the working group
“Consensus for treatment of chronic hepatitis C among drug addicts” was established to
define criteria for the treatment of hepatitis C that are specifically tailored to addiction medi-
cine. At the end of 1999 the Drug Forum, a national coordination body (cf. Chapters 1.1 and
11.2.1), discussed this subject in a meeting and proposed to turn to the National Health
Board as the national advisory and decision-making body for public health issues. Conse-
quently, in June 2000 the National Health Board started to discuss the subject of hepatitis
and drug addiction. A working group was established and prepared recommendations for a
set of measures based on the results reached so far in the other working groups dealing with
this subject. These recommendations will be discussed in a regular meeting of the National
Health Board in November 2000.
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Integrativwissenschaftlichen Fakultät der Universität Wien. Vienna (unpublished)
Zach, M., Haltmayer, J. und Neubauer, P. (1999). Hepatitis B - ein Impfprojekt für Drogen-
konsument(inn)en. Verein Wiener Sozialprojekte. Vienna
Database
EDDRA = Exchange on Drug Demand Reduction Action
Internet-Database of the EBDD: http://www.emcdda.org/databases
Austrian Projects in the EDDRA-Database:
Employment programme WALD  
(H.I.O.B. – Contacting and counselling centre for drug addicts, Vorarlberg)
Justizanstalt Wien-Favoriten (prison of Favoriten, Vienna) – Treatment and care of
addicted offenders at the prison of Favoriten, Vienna
(prison of Favoriten, Vienna)
Assisted Housing
(Vienna Social Projects Association VWS, Vienna)
Drug-free zone at the prison of Hirtenberg
(prison of Hirtenberg, Lower Austria)
Drug-free zones at the prison of Innsbruck
(prison of Innsbruck, the Tyrol)
Drug Out – therapy unit at the prison of Innsbruck
(prison of Innsbruck, the Tyrol)
Probation assistance for inmates at the prison of Favoriten, Vienna, provided by voluntary
staff
(Vienna Association of Probation Assistance and Social Help)
European Networking in addiction prevention
(Institute for Addiction Prevention, Upper Austria)
Fantasy instead of Ecstasy – addiction prevention through peergroup education in a
vocational high school at Neumarkt, Salzburg
(AKZENTE Salzburg – Addiction Prevention Unit, Salzburg)
Training course on addiction prevention in the kindergarten, for kindergarten teachers (will
be available on-line by the beginning of 2001)
(VIVID – Addiction Prevention Unit, Styria)
Promote health - prevent addiction – Action programme of the Federal Ministry of Education
and Cultural Affairs (since 1 April 2000: Federal Ministry of Education, Science and Culture)
H.I.O.B. Help – Information – Orientation – Counselling for Drug Addicts
(H.I.O.B. – contacting and counselling centre for drug addicts, Vorarlberg)
Youth counselling service WAGGON (will be available on-line by the beginning of 2001)
(TENDER – Association for youths work, Lower Austria)
Campaign „Empower our children”
(SUPRO – Addiction Prevention Unit of Vorarlberg, Vorarlberg)
Lukasfeld – short-term therapy department for persons addicted to illegal drugs
(Stiftung Maria Ebene, Vorarlberg)
Needles or Pins – European project to develop innovative projects for social and labour inte-
gration of people with drug related problems – Viennese sub-project
(Support and counselling centre for drug addicts and their relatives - DIALOG, Vienna)
Needles or Pins – European project to develop innovative projects for the social and
profesional rehabilitation of people with drug problems - sub-project of Vorarlberg
(Die Fähre, Vorarlberg)
Schweizer Haus Hadersdorf – Medical and psychosocial sanatorium
(Evangelisches Haus Hadersdorf – WOBES: Medizinische, Psychologische und Psychothera-
peutische Gesundheits- und Heilstätte „Schweizer Haus Hadersdorf“ (SHH) Ges.m.b.H., Wien)
Toyfree kindergarten. Addiction prevention by promoting life skills
(ISP – Information Centre for Addiction Prevention of the City of Vienna, Vienna)
Umbrella–Network–Project Austria - Switzerland: Analysis of problems with HIV, AIDS and
STDs in European border regions as well as development of co-operative, border-crossing
prevention methods (will be available on-line by the beginning of 2001)
(Institut für Sozialdienste, Vorarlberg)
Vienna Job Exchange – Vienna Job Exchange Association for the vocational integration of
persons who are addicted to (pharmaceutical) drugs and/or alcohol
(Vienna Job Exchange, Vienna)
81
ANNEX
A.  Drug Monitoring systems and
sources of information
B.  Tables, Figures, Maps
C.   List of Abbreviations
82
83
ANNEX A
Drug monitoring systems and
sources of information
84
85
Data source
Responsible institution
Type of data New developments and activities
Relevant monitoring and information systems at the federal level
Drug-related deaths -
special register
Federal Ministry for
Social Security and
Generations (FMSSG)
Fatalities directly (overdoses) or
indirectly (suicide, AIDS,
accidents, premature natural
death etc.) related to drugs
In order to secure continual up-dating, the FMSSG requires the
forensic medicine institutes to regularly pass on their autopsy
and toxicology records
In the course of implementing the key indicator “Drug-related
deaths”, a  comparative survey on the cases included in the
special register and in the general mortality register is carried
out, which aims at procuring information on the necessary
quality assurance measures.
Drug related deaths -
general mortality
register
Statistics Austria
Death cases with a drug-related
ICD-code for cause of death
In the course of implementing the key indicator “Drug-related
deaths”, a  comparative survey on the cases included in the
special register and in the general mortality register is carried
out, which aims at procuring information on the necessary
quality assurance measures.
Substitution treatment
FMSSG
Reports on the beginning  and
end of substitution treatment by
physician in charge of treatment
Because of incomplete reporting on the part of physicians, there
are considerations to change the data collection method.
Drug-specific treatment
and care
FMSSG
Aggregate statistics on clients
of drug services announced
according to Art. 15 Narcotic
Substances Act (NSA)
As the annual client statistics  submitted in the form of
aggregate data only permit a limited epidemiological analysis,
the FMSSG has convoked a working group to discuss the
establishment of a nationwide uniform treatment reporting
system that will meet EU requirements.
Register of drug users
reported according to
the Narcotic
Substances Act (NSA)
FMSSG
Person as well as episode-
specific data of all persons
reported to the FMSSG
according to Art. 24 NSA (esp.
in the context of reports to the
police, prosec ution, convictions
and alternatives to punishment)
The technical and structural basis of the register was improved
in 1999.
As a next step in making data processing more efficient, a
simplified method of electronic data transmission is currently
developed by the FMI (see below under Reports) .
Reports to the police
for violation of the NSA
Federal Ministry of the
Interior (FMI)
Episode-specific data on all
reports for violation of the NSA
registered by federal and
province police  or customs
authorities (double counting can
not be excluded)
As of the beginning of 2000 an on-line network of all the units
involved was installed. Now the units can transmit the reports
on-line to the head office.
Amphetamines, which had not been indicated separately in
1998 and 1999,  have been reintroduced as a separate
category as of
1 January 2000.
Seizures of narcotic
Drugs
FMI
Number and quantity of
seizures registered by federal
and province police  or customs
authorities
As of the beginning of 2000, an on-line network of all the units
involved was installed. Now, the units can transmit the reports
on-line to the head office
Amphetamines, which had not been indicated separately in
1998 and 1999,  have been  reintroduced as a separate
category as of
1 January 2000.
Convictions under the
NSA
Statistics Austria
Number of convictions under
the NSA and type of
punishment
No new developments
Relevant monitoring and information systems at the provincial level
Vienna
Drug Coordination Office
of the City of Vienna
Data on the number of clients
and services rendered by the
drug help facilities; drug-related
deaths; substitution treatment;
overdoses; ambulance services
required; population surveys
The Vienna monitoring system collects a variety of data (see
Type of data) and is continually developed further: a working
group has been established to develop a uniform
documentation system, which will comprise data on the clients,
services and structure of the drug help facilities on a long-term
basis. Furthermore, in 1999 another population survey  on
consumption experience and attitudes was organised (with the
same design as the 1993, 1995 and 1997 surveys).
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Data source
Responsible
institution
Type of data New developments and activities
Upper Austria
Drug Coordination of
Upper Austria
Data on the number of clients
and services rendered by the
drug help facilities; drug-related
deaths; substitution treatment;
In Upper Austria the monitoring system already collects a
variety of data (see Type of data). The current additional “Rapid
Assessment“ pilot project has been initiated with the aim  to
provide a pool of regularly collected data in order to facilitate
rapid analyses of  drug situation developments.
Other provinces
Drug Coordination
Data on the number of clients
and services rendered by the
drug help facilities; drug-related
deaths; substitution treatment;
examinations according to the
NSA
In all other provinces, the monitoring and information systems
vary. Almost all of them collect data from the regional drug help
facilities, substitution treatment and drug-related deaths. In
many provinces the monitoring system will yet be further
expanded.
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Table A1: Estimated expenses related to illegal drugs in Austria in 1997
Area Expenses in million ATS Expenses  in million EURO
Law enforcement - total 1330.5 96.7
- federal and province police 651.0 47.3
- courts (criminal procedure) 111.0 8.1
- courts (prison sentences) 568.5 41.3
Health and social services - total 690.9 50.2
- inpatient treatment (hospitals) 213.2 15.5
- specialised residential treatment 263.0 19.1
- specialised outpatient treatment 184.0 13.4
- low-threshold services (VWS) 30.7 2.2
Prevention 39.2 2.9
Note: No estimates are available for expenditures related to offences in connection with drug acquisition and other drug-related
offences, substitution treatment and after care/reintegration. The figure for low-threshold services refers exclusively to the
services provided by the Vienna Social Projects Association (VWS).
Source: Bruckner and Zederbauer 2000
Table A2: Overview of selected studies on drug experience among the Austrian population, published
between 1996 and 2000
Study
(year of publication)
Area covered
year of data-
colle ction
(period covered)
Target group
(sample)
Drug types surveyed Percentage of
respondents with
drug experience
Age group             %
Schulstudie Kärnten /
school survey Carinthia
(Bohrn/Bohrn 1996)
Carinthia
1996
(lifetime)
students in their 7th
to 12th/13th school
year
(n = 1,234)
hashish
ecstasy
LSD
cocaine
heroin
13 - 19
13 - 19
13 - 19
13 - 19
13 - 19
7.7
3.2
1.0
0.3
0.3
NÖ Jugendstudie /
youth survey Lower Austria
(Brunmayr 1997)
Lower Austria
1996/97
(lifetime)
students in their 9th
to 12th/13th school
year
(n = 1,300)
hashish
ecstasy
hallucinants
cocaine
heroin
15 - 19
15 - 19
15 - 19
15 - 19
15 - 19
20
4
> 1
> 1
>1
Schulstudie NÖ /
school survey Lower A ustria
(Institut für Sozial- und
Gesundheitspsychologie
1999)
Lower Austria
1997
(lifetime)
students in their 7th
to
12th school year
(n = 1,899)
cannabis
ecstasy
LSD
cocaine
heroin
13 - 18
13 - 18
13 - 18
13 - 18
13 - 18
13.6
3.8
1.7
1.3
0.6
Linzer Suchmittelstudie /
drug survey Linz
(Institut für Soziologie der
Universität Linz, undated)
Linz
1998
(lifetime)
general population
aged 15 and older
(n = 394)
cannabis
cannabis
cannabis
cannabis
cannabis
15 – 19
20 – 29
30 – 39
40 – 49
50 +
28
37
19
7
5
Jugendstudie Tirol /
youth survey, the Tyrol
(Schüßler et al. 2000)
Innsbruck
1999
(lifetime)
Youths aged
14 to 19
(n = 493)
hashish
other illegal drugs
14 - 19
14 - 19
22
3
Wiener Suchtmittelstudie /
Vienna drug survey
(IFES 2000)
Vienna
1999
(lifetime)
general population
aged 16 and older
(n = 600)
cannabis
ecstasy
amphetamines
cocaine
opiates
other illegal drugs
16 +
16 +
16 +
16 +
16 +
16 +
11
1
1
1 - 2
1
1 - 2
Summarised by ÖBIG
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Table A3: Lifetime prevalence of illegal drugs among the Viennese population in Vienna
aged 16 years and older 1993 - 1999
1993 1995 1997 1999
Hemp products such as hashish, marijuana 5 7 12 11
Ecstasy - - 2 1
Amphetamines, speed - - 2 1
Opiates such as opium, morphine, heroin, methadone 1 1 1-2 1
Cocaine 1 1 1 1-2
Other illegal drugs, e. g. LSD 1 1 1-2 1-2
- = not included
Source: IFES 2000
Table A4: Overview of the results of a prevalence estimate of problem opiate consumption in Austria
1995
Group Estimate 95 % confidence interval
Austria, men and women, 15 to 54 years old 17,276 15,984 - 18,731
Austria, men, 15 to 54 years old 10,001 8,318 - 12,289
Austria, women, 15 to 54 years old 3,874 3,371  - 4,499
Austria, men and women, 15 to 24 years old 3,971 3,574  - 4,444
 Austria, men and women, 25 to 34 years old 8,242 7,383  - 9,258
 Austria, men and women, 35 to 54 years old 3,505 2,899  - 4,316
Vienna, men and women, 15 to 54 years old 10,953 9,865 - 12,232
General information and method: prevalence estimate of the number of „problem opiate users“ in Austria; age range: 15 to 54
years; period covered: October 1994 to November 1995; method: 3-sample-capture-recapture: substitution treatments (all
substitution treatments reported to the Federal Ministry for Social Security and Generations); drug related deaths (all fatalities
directly (overdoses) or indirectly (AIDS, accidents, suicides etc.) related to drugs); reports to the police (all reports for violation of
the Narcotic Drugs Act registered at the police in the context of opiates).
The study served as a methodological pilot project and, thus, made use of additional methods (multiplier; truncated Poisson)  in
order to verify the results of the capture-recapture estimate. The results presented above were discussed with a “reference
group” of Austrian experts and were judged as consistent/reliable.
Source: Uhl and Seidler 2000
Table A5: Number of drug fatalities in Austria by cause of death from 1990 to 1999
Cause of death 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999
Intoxication by narcotic drugs only 124 106 70 37 25
Polydrug intoxication including narcotic
drugs
42 73 62 71 101
(Multiple) intoxication without narcotic drugs 14 7 7 24 34 6 12 3 4 7
Suicide 7 5 10 7 16 15 11 14 13 15
AIDS 22 26 39 47 41 28 23 9 20 11
Other causes 4 8 10 18 19 26 5 14 17 15
Total 83 116 187 226 250 241 230 172 162 174
Note: The distinction between narcotic drugs only and polydrug intoxication was first used in 1995.
70 121361304
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Source: FMSSG, Dep. VIII/B/12
Table A6: Number of drug fatalities in Austria by province from 1990 to 1999
Province 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 1990 - 1999
Burgenland 2 0 1 1 4 3 2 3 2 0 18
Carinthia 3 3 4 3 6 4 3 8 5 7 46
Lower Austria 1 4 6 10 10 11 18 13 11 12 96
Upper Austria 8 16 20 15 27 24 17 10 14 5 156
Salzburg 4 1 3 3 5 7 6 12 13 9 63
Styria 5 1 7 5 5 8 10 13 6 6 66
Tyrol 4 10 12 28 26 23 18 15 18 21 175
Vorarlberg 12 19 19 18 20 24 20 7 13 10 162
Vienna 44 62 115 143 147 137 136 91 80 104 1,059
Total 83 116 187 226 250 241 230 172 162 174 1,841
Source: FMSSG, Dep. VIII/B/12
Table A7: Number of drug fatalities in Austria by age group and total by gender from 1990 to 1999
Age group 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999
abs. % abs. % abs. % abs. % abs. % abs. % abs. % abs. % abs. % abs. %
< 19 4 5 2 2 22 12 32 14 34 13 33 14 24 10 20 12 8 5 19 11
20 - 24 13 16 22 19 40 21 63 28 55 22 40 16 47 20 38 22 41 25 27 15
25 - 29 21 25 36 31 42 23 38 17 42 17 46 19 36 16 26 15 26 16 27 15
30 - 34 27 33 39 34 47 25 56 25 65 26 62 26 54 24 33 19 26 16 39 23
35 - 39 16 19 13 11 25 13 32 14 42 17 41 17 45 20 30 17 27 17 38 22
40 and older 2 2 4 3 11 6 5 2 12 5 19 8 24 10 25 15 34 21 24 14
Total 83 100 116 100 187 100 226 100 250 100 241 100 230 100 172 100 162 100 174 100
Women 14 17 24 21 33 18 39 17 40 16 45 19 36 16 29 17 24 15 48 28
Men 69  83 92 79 154 82 187 83 210 84 196 81 194 84 143 83 138 85 126 72
abs. = in absolute figures
Source: FMSSG, Dep. VIII/B/12
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Table A8: Distribution of drug fatalities in Austria by cause of death and age in 1999
Age
group
Overdose Premature natural
death (disease)
Unnatural death Total
Narcotic
drugs only
Polydrug intoxication
including narcotic
drugs
(Multiple)
intoxication without
narcotic drugs
AIDS Other cause Traumatic cause,
accident, unknown
< 17 7 1 0 0 0 1 9
18 - 19 2 6 0 0 0 2 10
20 - 24 3 19 1 0 0 4 27
25 - 29 4 17 2 0 0 4 27
30 - 34 3 23 1 3 6 3 39
35 - 39 6 19 3 5 2 3 38
40 and older 1 17 1 3 1 1 24
Total 26 102 8 11 9 18 174
Percentage 15 59 5 6 5 10 100
Men 17 77 4 8 7 13 126
Percentage 65 75 50 73 78 72 72
Note: The table is based on the new distinction by cause of death first used in 1995. Therefore the results are different to those
in Table A5.
Source: FMSSG, Dep. VIII/B/12
Table A9: Distribution of drug fatalities in Austria by cause of death and province in 1999
Province Overdose Premature natural
death (disease)
Unnatural death Total %
Narcotic
drugs only
Polydrug
intoxication
including
narcotic drugs
(Multiple)
intoxication
without narcotic
drugs
AIDS Other cause Traumatic cause,
accident, unknown
Burgenland 0 0 0 0 0 0 0 0.0
Carinthia 1 6 0 0 0 0 7 4.0
Lower Austria 2 5 1 0 1 3 12 7.0
Upper Austria 0 2 0 2 0 1 5 2.9
Salzburg 0 5 2 0 0 2 9 5.2
Styria 0 5 1 0 0 0 6 3.5
Tyrol 1 11 2 6 0 1 21 12.1
Vorarlberg 0 5 0 1 0 4 10 5.8
Vienna 22 63 2 2 8 7 104 59.8
Total 26 102 8 11 9 18 174 100
Source: FMSSG, Dep. VIII/B/12
Table A10: Development of AIDS cases in Austria by risk situation from 1990 to 1999
Risk situation 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999
Homosexual-bisexual contact 68 74 77 90 71 69 58 23 28 23
Intravenous drug use 45 56 57 59 41 39 25 21 24 22
Heterosexual contact 25 27 30 30 27 34 21 15 23 29
Other cause / unknown 26 42 27 54 26 62 34 35 19 16
Total 164 199 191 233 165 204 138 94 94 90
Source: FMSSG, Dep. VIII/D/2
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Table A11: Distribution of reports to the police for violations of the Narcotic Drugs Act/Narcotic
Substances Act in Austria by first offenders and repeat offenders and development
from 1990 to 1999
Reports 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999
Total number of reports 4,829 5,392 7,805 10,915 12,623 13,093 16,196 17,868 17,141 17,59
7
First offenders 2,077 2,185 3,616 4,788 5,281 5,521 8,322 9,278 8,672 9,868
Repeat offenders 2,586 2,918 3,893 5,882 7,117 7,313 7,511 8,325 8,228 7,463
Difference between sum of individual province figures and total figure = unknown offenders
1998/1999: all reports, not only narcotic drugs but also psychotropic substances
Note: On 1 January 1998 the Narcotic Drugs Act was replaced by the Narcotic Substances Act.
Source: FMI – Annual Reports on Drug Delinquency in Austria
Table A12: Distribution of reports to the police for violations of the Narcotic Drugs Act/
Narcotic Substances Act in Austria by province from 1990 to 1999
Province 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999
Burgenland 227 309 368 332 343 669 694 759 707 603
Carinthia 221 260 355 334 524 534 1,280 961 1,076 1,208
Lower Austria 619 767 1,055 1,216 1,772 1,655 1,550 2,686 2,519 2,389
Upper Austria 545 564 936 992 1,133 1,405 1,941 2,256 2,334 1,946
Salzburg 218 250 268 504 436 355 962 855 1,053 840
Styria 436 419 340 458 739 851 1,093 1,125 973 1,367
Tyrol 484 468 842 1,483 1,798 1,382 2,268 2,204 2,212 2,152
Vorarlberg 467 405 748 973 888 1,082 1,040 933 1,114 1,848
Vienna 1,612 1,950 2,893 4,623 4,990 5,160 5,368 6,089 4,606 4,858
Total 4,829 5,392 7,805 10,915 12,623 13,093 16,196 17,868 16,624 17,211
Difference between sum of individual province figures and total figure = reports not attributable to province
1998/1999: For the purpose of comparison only reports related to drugs have been considered.
Note: On 1 January 1998 the Narcotic Drugs Act was replaced by the Narcotic Substances Act.
Source: FMI - Annual Reports on Drug Delinquency in Austria
Table A13: Distribution of reports to the police for violations of the Narcotic Drugs Act/
Narcotic Substances Act in Austria by drug type from 1990 to 1999
Drug type 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999
Cannabis 4,201 4,132 5,889 7,913 9,552 9,845 14,456 16,124 16,376 17,236
Heroin and opiates 1,176 1,527 2,803 4,340 4,394 4,386 3,727 3,434 2,850 2,524
Cocaine 637 643 819 1,267 1,404 1,603 1,912 2,764 2,103 2,608
LSD 186 149 200 296 234 315 640 893 736 532
Ecstasy - - - - 116 496 1,375 1,942 1,411 1,517
Amphetamines - - - 103 81 342 1,068 - -
Other drugs 211 182 222 226 306 302 430 850 - -
- = not evaluated separately or not specified
Note: On 1 January 1998 the Narcotic Drugs Act was replaced by the Narcotic Substances A ct.
Because of data broken down by type of drug one report may have been listed under several headings, therefore the
figures differ from the total number of reports.
Source: FMI – Annual Reports on Drug Delinquency in Austria
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Table A14: Distribution of reports to the police for violations of the Narcotic Substance Act in Austria
by drug type and province in 1999
Drug type B K NÖ OÖ S ST T V W Total
Cannabis 711 1,457 2,796 2,260 805 1,805 2,509 2,140 2,753 17,236
Heroin and opiates 18 56 210 108 226 135 219 198 1,354 2,524
Cocaine 27 92 301 219 116 201 205 236 1,211 2,608
LSD 18 33 173 75 27 72 24 62 48 532
Ecstasy 55 140 335 289 55 194 93 248 108 1,517
Note: Because of data broken down by type of drug one report may have been listed under several headings, therefore the
figures differ from the total number of reports.
Source: FMI – Annual Reports on Drug Delinquency in Austria
Table A15: Convictions under the Narcotic Drugs Act/Narcotic Substances Act and total number of
convictions in Austria from 1990 to 1999
Year Convictions in AustriaTotal number of convictions
Under the NDA /NSA
Convictions under
Art. 12 NDA/Art. 28
NSA
Convictions under
Art. 16 NDA/Art. 27
NSA
Total number Under the NDA /NSA
(percentage)
1990 1,131 369 747 71,722 1.6
1991 1,469 503 947 75,155 2.0
1992 1,720 617 1,074 74,419 2.3
1993 2,683 952 1,700 74,937 3.6
1994 3,275 1,230 2,010 69,458 4.7
1995 3,261 1,124 2,102 69,779 4.7
1996 3,454 1,027 2,382 66,980 5.2
1997 3,797 1,036 2,717 65,040 5.8
1998 3,327 1,041 2,207 63,864 5.2
1999 3,359 1,022 2,230 61,954 5.4
NDA = Narcotic Drugs Act
NSA = Narcotic Substances Act
On 1 January 1998 the Narcotic Drugs Act was replaced by the Narcotic Substances Act.
Art. 12 NDA / Art. 28 NSA = trafficking, possession, etc. of large quantities of narcotic drugs (“commercial trafficking”)
Art. 16 NDA / Art. 27 NSA = trafficking, possession, etc. of small quantities of narcotic drugs
Note: These figures only refer to the ”leading“ offence, i.e. the offence with the highest range of punishment, so not all
convictions under the NDA, or the NSA, respectively, are covered.
Source: Statistics Austria - Criminal Court Statistics
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Table A16: Final convictions under the Narcotic Drugs Act/Narcotic Substances Act in Austria by age,
gender and reason for conviction in 1999
Reason for conviction 14 - 19 years 20 - 24 years 25 - 30 years 31 - 35 years > 35 years Total
NDA/NSA total men 456 1,010 542 403 545 2,956
women 56 141 80 60 82 403
Art. 12 NDA / Art. 28 NSA men 105 245 196 136 245 906
women 16 35 28 15 33 116
Art. 16 NDA / Art. 27 NSA men 350 752 398 241 265 1,961
women 40 103 50 43 41 269
NDA = Narcotic Drugs Act
NSA = Narcotic Substances Act
On 1 January 1998 the Narcotic Drugs Act was replaced by the Narcotic Substances Act.
Art. 12 NDA / Art. 28 NSA = trafficking, possession, etc. of large quantities of narcotic drugs (“commercial trafficking“)
Art. 16 NDA / Art. 27 NSA = trafficking, possession, etc. of small quantities of narcotic drugs
Note: These figures only refer to the „leading“ offence, i.e. the offence with the highest range of punishment, so not all
convictions under the NDA, or the NSA, respectively, are covered.
Source: Statistics Austria – Criminal Court Statistics
Table A17: Final convictions under the Narcotic Drugs Act/Narcotic Substances Act, according to
youths and adults, reason for conviction and form of punishment in 1999
Reason for conviction Fine Prison sentence Other
punishment1
Total
Probation No probation Partial probation
NDA/NSA total youths 130 104 33 37 114 418
adults 1,148 707 770 281 35 2,941
youths 11 41 14 30 0 96Art. 12 NDA / Art. 28 NSA
(felonies) adults 23 181 534 181 7 926
youths 119 63 19 7 113 321Art. 16 NDA / Art. 27 NSA
(misdemeanours) adults 1,088 499 203 92 27 1,909
youths = persons younger than 19 at the time of the offence
NDA = Narcotic Drugs Act
NSA = Narcotic Substances Act
Art. 12 NDA / Art. 28 NSA = trafficking, possession, etc. of large quantities of narcotic drugs (“commercial trafficking“)
Art. 16 NDA / Art. 27 NSA = trafficking, possession, etc. of small quantities of narcotic drugs
1 Other punishment: partial probation (Art. 43 A (2) CC), referrals to institutions (Art. 21 (1) CC) or Art. 21 (2), Art. 22, Art. 23
CC), no additional punishment (Art. 40 CC) and, though only in the case of youths, conviction with punishment reserved (Art.
13 JCA), conviction without punishment (Art. 12 JCA)
Note: These figures only refer to the “leading“ offence, i.e. the offence with the highest range of punishment, so not all
convictions under the NDA, or the NSA, respectively, are covered.
Source: Statistics Austria – Criminal Court Statistics
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Table A18: Number of seizures of narcotic drugs in Austria from 1990 to 1999
Drug type 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999
Cannabis 1,480 1,485 2,334 2,953 3,510 3,757 4,838 4,957 4,683 5,079
Heroin 268 435 859 1,289 1,225 1,298 1,110 861 654 452
Cocaine 135 158 235 332 376 421 525 651 531 519
Amphetamines 2 4 14 26 103 43 136 221 - -
LSD 31 30 51 58 50 80 102 113 61 56
Ecstasy - - - - 51 153 254 253 135 215
- = not evaluated separately or not specified
Source: FMI - Annual Reports on Drug Delinquency in Austria
Table A19: Seizures of drugs in Austria by quantity from 1990 to 1999
Drug type 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999
Cannabis (kg) 320 12,166 248 546 394 697 517 912 1.336 451
Heroin (kg) 72.3 102.8 78.2 104.8 80.2 47.0 81.3 102 118 78
Cocaine (kg) 41.2 84.4 58.1 83.9 52.6 55.3 72.7 87 99 63
Amphetamines (kg) 0.2 0.3 0.4 0.3 0.7 1.6 3.7 7.9 - -
LSD (Dosis) 418 906 3.847 28,201 1,543 2,602 4,166 5,243 2,494 2,811
Ecstasy (Dosis) - - - - 3,003 31,338 25,118 23,522 114,677 31,129
- = not evaluated separately or not specified
Source: FMI - Annual Reports on Drug Delinquency in Austria
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Table A20: Austrian population statistics by age group and gender 1999
Age group Men Women Total
0 to 4 years 219,851 209,469 429,320
5 to 9 years 242,616 230,930 473,546
10 to 14 years 239,631 227,913 467,544
15 to 19 years 247,792 236,357 484,149
20 to 24 years 240,251 235,555 475,806
25 to 29 years 300,248 300,228 600,476
30 to 34 years 364,841 350,203 715,044
35 to 39 years 358,919 341,202 700,121
40 to 44 years 301,854 291,622 593,476
45 to 49 years 260,856 256,218 517,074
50 to 54 years 242,623 241,608 484,231
55 to 59 years 257,445 266,782 524,227
60 to 64 years 180,656 195,512 376,168
65 to 69 years 162,064 191,035 353,099
70 to 74 years 135,738 198,378 334,116
75 to 79 years 95,174 190,475 285,649
80 to 84 years 39,932 90,462 130,394
85 and older 38,511 109,303 147,814
Total 3,929,002 4,163,252 8,092,254
0 to 14 years 702,098 668,312 1,370,410
15 to 29 years 788,291 772,140 1,560,431
30 to 44 years 1,025,614 983,027 2,008,641
45 to 59 years 760,924 764,608 1,525,532
60 to 74 years 478,458 584,925 1,063,383
75 and older 173,617 390,240 563,857
Total 3,929,002 4,163,252 8,092,254
Source: Statistics Austria, calculation by ÖBIG
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Figure A1: Organisational structure of the drug sector in Austria (overview)
99
 Figure A2: Attitude of the population in Vienna on drug policy measures over time, 1995 - 1999
Source: Feistritzer 2000
Figure A3: Number of syringes sold or exchanged in the context of the syringe programme in the open
drug scene in Vienna from 1993 - 1999
Source: Drug Co-ordination Office of the City of Vienna
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ANNEX C
List of Abbreviations
104
105
AMS Public Employment Service
ATS Austrian Schillings
CC Criminal Code
DF Drug Forum
EDDRA Exchange on Drug Demand Reduction Action
EDPW European Drug Prevention Week
EMCDDA European Monitoring Centre for Drugs and Drug Addiction
EU European Union
FMAFEW Federal Ministry of Agriculture, Forestry, Environment and Water Management
FMD Federal Ministry of Defence
FMESC Federal Ministry of Education, Science and Culture
FMF Federal Ministry of Finance
FMFA Federal Ministry for Foreign Affairs
FMI Federal Ministry of the Interior
FMJ Federal Ministry of Justice
FMSSG Federal Ministry for Social Security and Generations
FMTIT Federal Ministry for Transport, Innovation and Technology
HAF Healthy Austria Fund
IFES Institute for Empirical Research
JCA Juvenile Court Act
MDMA methylenedioxymethamphetamine
NDA Narcotic Drugs Act
NSA Narcotic Substances Act
ÖBIG Austrian Health Institute
PMA paramethoxyamphetamine
REITOX European Information Network on Drugs and Drug Addiction
(Réseau Européen d’Information sur les Drogues et les Toxicomanies)
UNDCP United Nations International Drug Control Programme
VWS Vienna Social Projects Association
